(State of incorporation) | (I.R.S. Employer Identification No.) |
OneMain Holdings, Inc.: | ||||||||||||||
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
OneMain Finance Corporation: None |
OneMain Holdings, Inc.: | |||||||||||||||||||||||||||||
☑ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | Emerging growth company | |||||||||||||||||||||||
OneMain Finance Corporation: | |||||||||||||||||||||||||||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | ☑ | Smaller reporting company | Emerging growth company |
Term or Abbreviation | Definition | |||||||
30-89 Delinquency ratio | net finance receivables 30-89 days past due as a percentage of net finance receivables | |||||||
ABS | asset-backed securities | |||||||
Adjusted pretax income (loss) | a non-GAAP financial measure used by management as a key performance measure of our segment | |||||||
AETR | annual effective tax rate | |||||||
AHL | American Health and Life Insurance Company, an insurance subsidiary of OneMain Financial Holdings, LLC | |||||||
Annual Report | the Annual Report on Form 10-K of OMH and OMFC for the fiscal year ended December 31, 2023, filed with the SEC on February 13, 2024 | |||||||
ASC | Accounting Standards Codification | |||||||
ASU | Accounting Standards Update | |||||||
ASU 2022-02 | The accounting standard issued by FASB in March of 2022, Financial Instruments - Credit Losses: Troubled Debt Restructurings and Vintage Disclosures | |||||||
Auto finance | financing at the point of purchase through a network of auto dealerships | |||||||
Average daily debt balance | average of debt for each day in the period | |||||||
Average net receivables | average of net finance receivables for each day in the period | |||||||
Base Indenture | indenture, dated as of December 3, 2014, by and between OMFC and Wilmington Trust, National Association, as trustee, and guaranteed by OMH | |||||||
Board | the OMH Board of Directors | |||||||
C&I | Consumer and Insurance | |||||||
CDO | collateralized debt obligations | |||||||
CMBS | commercial mortgage-backed securities | |||||||
Consumer loans | consist of personal loans and auto finance | |||||||
Exchange Act | Securities Exchange Act of 1934, as amended | |||||||
FASB | Financial Accounting Standards Board | |||||||
Foursight | Foursight Capital LLC | |||||||
GAAP | generally accepted accounting principles in the United States of America | |||||||
GAP | guaranteed asset protection | |||||||
Gross charge-off ratio | annualized gross charge-offs as a percentage of average net receivables | |||||||
Gross finance receivables | the unpaid principal balance of our consumer loans. For precompute personal loans, unpaid principal balance is the gross contractual payments less the unaccreted balance of unearned finance charges. Credit card gross finance receivables equal the unpaid principal balance, billed interest, and fees | |||||||
Indenture | the Base Indenture, together with all subsequent Supplemental Indentures | |||||||
Junior Subordinated Debenture | $350 million aggregate principal amount of 60-year junior subordinated debt issued by OMFC under an indenture dated January 22, 2007, by and between OMFC and Deutsche Bank Trust Company, as trustee, and guaranteed by OMH | |||||||
KBRA | Kroll Bond Rating Agency, Inc. | |||||||
Managed receivables | consist of our C&I net finance receivables and finance receivables serviced for our whole loan sale partners | |||||||
Modified finance receivables | finance receivable contractually modified, subsequent to the adoption of ASU 2022-02 on January 1, 2023, as a result of the borrower’s financial difficulties | |||||||
Moody’s | Moody’s Investors Service, Inc. | |||||||
Net charge-off ratio | annualized net charge-offs as a percentage of average net receivables | |||||||
Net finance receivables | gross finance receivables plus deferred origination costs. Consumer loans also include accrued finance charges and fees and exclude unearned fees | |||||||
Net interest income | interest income less interest expense | |||||||
Term or Abbreviation | Definition | |||||||
ODART | OneMain Direct Auto Receivables Trust | |||||||
OMFC | OneMain Finance Corporation | |||||||
OMFCT | OneMain Financial Credit Card Trust | |||||||
OMFIT | OneMain Financial Issuance Trust | |||||||
OMH | OneMain Holdings, Inc. | |||||||
OneMain | OneMain Holdings, Inc. and OneMain Finance Corporation, collectively with their subsidiaries | |||||||
Open accounts | consist of credit card accounts that are not charged-off or closed accounts with a zero balance as of period end | |||||||
Other securities | primarily consist of equity securities and those securities for which the fair value option was elected. Other securities recognize unrealized gains and losses in investment revenues | |||||||
Personal loans | loans secured by titled collateral or unsecured and offered through our branch network, central operations, or digital platform | |||||||
Pretax capital generation | a non-GAAP financial measure used by management as a key performance measure of our segment, defined as C&I adjusted pretax income (loss) excluding the change in C&I allowance for finance receivable losses | |||||||
Private Secured Term Funding | $350 million aggregate principal amount of debt collateralized by our consumer loans issued on April 25, 2022 | |||||||
Purchase volume | consists of credit card purchase transactions in the period, including cash advances, net of returns | |||||||
Recovery ratio | annualized recoveries on net charge-offs as a percentage of average net receivables | |||||||
RMBS | residential mortgage-backed securities | |||||||
S&P | S&P Global Ratings | |||||||
SEC | U.S. Securities and Exchange Commission | |||||||
Securities Act | Securities Act of 1933, as amended | |||||||
Segment Accounting Basis | a basis used to report the operating results of our C&I segment and our Other components, which reflects our allocation methodologies for certain costs and excludes the impact of applying purchase accounting | |||||||
SpringCastle Portfolio | loans the Company previously owned and now services on behalf of a third party | |||||||
Supplemental Indentures | collectively, the following supplements to the Base Indenture: Fifth Supplemental Indenture, dated as of March 12, 2018; Sixth Supplemental Indenture, dated as of May 11, 2018; Eighth Supplemental Indenture, dated as of May 9, 2019; Ninth Supplemental Indenture, dated as of November 7, 2019; Eleventh Supplemental Indenture, dated as of December 17, 2020; Twelfth Supplemental Indenture, dated as of June 22, 2021; Thirteenth Supplemental Indenture, dated as of August 11, 2021; Fourteenth Supplemental Indenture, dated June 20, 2023; Fifteenth Supplemental Indenture, dated June 22, 2023; and Sixteenth Supplemental Indenture, dated as of December 13, 2023 | |||||||
Triton | Triton Insurance Company, an insurance subsidiary of OneMain Financial Holdings, LLC | |||||||
Unearned finance charges | the amount of interest that is capitalized at time of origination on a precompute loan that will be earned over the remaining contractual life of the loan | |||||||
Unencumbered receivables | unencumbered unpaid principal balance of our consumer loans and credit cards. For precompute personal loans, unpaid principal balance is the gross contractual payments less the unaccreted balance of unearned finance charges. Credit cards exclude billed interest, fees, and closed accounts with balances | |||||||
Unsecured corporate revolver | unsecured revolver with a maximum borrowing capacity of $1.3 billion, payable and due on October 25, 2026 | |||||||
Unsecured Notes | the notes, on a senior unsecured basis, issued by OMFC and guaranteed by OMH | |||||||
VIEs | variable interest entities | |||||||
VFN | variable funding note | |||||||
Weighted average interest rate | annualized interest expense as a percentage of average debt | |||||||
XBRL | eXtensible Business Reporting Language | |||||||
Yield | annualized finance charges as a percentage of average net receivables |
Item 1. Financial Statements. |
(dollars in millions, except par value amount) | March 31, 2024 | December 31, 2023 | ||||||||||||
Assets | ||||||||||||||
Cash and cash equivalents | $ | $ | ||||||||||||
Investment securities (includes available-for-sale securities with a fair value and an amortized cost basis of $ | ||||||||||||||
Net finance receivables (includes loans of consolidated VIEs of $ | ||||||||||||||
Unearned insurance premium and claim reserves | ( | ( | ||||||||||||
Allowance for finance receivable losses (includes allowance of consolidated VIEs of $ | ( | ( | ||||||||||||
Net finance receivables, less unearned insurance premium and claim reserves and allowance for finance receivable losses | ||||||||||||||
Restricted cash and restricted cash equivalents (includes restricted cash and restricted cash equivalents of consolidated VIEs of $ | ||||||||||||||
Goodwill | ||||||||||||||
Other intangible assets | ||||||||||||||
Other assets | ||||||||||||||
Total assets | $ | $ | ||||||||||||
Liabilities and Shareholders’ Equity | ||||||||||||||
Long-term debt (includes debt of consolidated VIEs of $ | $ | $ | ||||||||||||
Insurance claims and policyholder liabilities | ||||||||||||||
Deferred and accrued taxes | ||||||||||||||
Other liabilities (includes other liabilities of consolidated VIEs of $ | ||||||||||||||
Total liabilities | ||||||||||||||
Contingencies (Note 12) | ||||||||||||||
Shareholders’ equity: | ||||||||||||||
Common stock, par value $ | ||||||||||||||
Additional paid-in capital | ||||||||||||||
Accumulated other comprehensive loss | ( | ( | ||||||||||||
Retained earnings | ||||||||||||||
Treasury stock, at cost; | ( | ( | ||||||||||||
Total shareholders’ equity | ||||||||||||||
Total liabilities and shareholders’ equity | $ | $ |
Three Months Ended March 31, | ||||||||||||||
(dollars in millions, except per share amounts) | 2024 | 2023 | ||||||||||||
Interest income | $ | $ | ||||||||||||
Interest expense | ||||||||||||||
Net interest income | ||||||||||||||
Provision for finance receivable losses | ||||||||||||||
Net interest income after provision for finance receivable losses | ||||||||||||||
Other revenues: | ||||||||||||||
Insurance | ||||||||||||||
Investment | ||||||||||||||
Gain on sales of finance receivables | ||||||||||||||
Other | ||||||||||||||
Total other revenues | ||||||||||||||
Other expenses: | ||||||||||||||
Salaries and benefits | ||||||||||||||
Other operating expenses | ||||||||||||||
Insurance policy benefits and claims | ||||||||||||||
Total other expenses | ||||||||||||||
Income before income taxes | ||||||||||||||
Income taxes | ||||||||||||||
Net income | $ | $ | ||||||||||||
Share Data: | ||||||||||||||
Weighted average number of shares outstanding: | ||||||||||||||
Basic | ||||||||||||||
Diluted | ||||||||||||||
Earnings per share: | ||||||||||||||
Basic | $ | $ | ||||||||||||
Diluted | $ | $ |
Three Months Ended March 31, | ||||||||||||||
(dollars in millions) | 2024 | 2023 | ||||||||||||
Net income | $ | $ | ||||||||||||
Other comprehensive income (loss): | ||||||||||||||
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities | ( | |||||||||||||
Foreign currency translation adjustments | ( | |||||||||||||
Changes in discount rate for insurance claims and policyholder liabilities | ||||||||||||||
Other | ( | |||||||||||||
Income tax effect: | ||||||||||||||
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities | ( | |||||||||||||
Foreign currency translation adjustments | ||||||||||||||
Changes in discount rate for insurance claims and policyholder liabilities | ( | ( | ||||||||||||
Other comprehensive income (loss), net of tax | ( | |||||||||||||
Comprehensive income | $ | $ |
OneMain Holdings, Inc. Shareholders’ Equity | ||||||||||||||||||||||||||||||||||||||
(dollars in millions) | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income (Loss) | Retained Earnings | Treasury Stock | Total Shareholders’ Equity | ||||||||||||||||||||||||||||||||
Three Months Ended March 31, 2024 | ||||||||||||||||||||||||||||||||||||||
Balance, January 1, 2024 | $ | $ | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||||||||||||
Common stock repurchased | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||
Treasury stock issued | — | — | — | — | ||||||||||||||||||||||||||||||||||
Share-based compensation expense, net of forfeitures | — | — | — | — | ||||||||||||||||||||||||||||||||||
Withholding tax on share-based compensation | — | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||
Other comprehensive loss | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||
Cash dividends (a) | — | — | — | ( | — | ( | ||||||||||||||||||||||||||||||||
Net income | — | — | — | — | ||||||||||||||||||||||||||||||||||
Balance, March 31, 2024 | $ | $ | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||||||||||||
Three Months Ended March 31, 2023 | ||||||||||||||||||||||||||||||||||||||
Balance, January 1, 2023 | $ | $ | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||||||||||||
— | — | — | — | |||||||||||||||||||||||||||||||||||
Balance, January 1, 2023 (post-adoption) | ( | ( | ||||||||||||||||||||||||||||||||||||
Common stock repurchased | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||
Treasury stock issued | — | — | — | — | ||||||||||||||||||||||||||||||||||
Share-based compensation expense, net of forfeitures | — | — | — | — | ||||||||||||||||||||||||||||||||||
Withholding tax on share-based compensation | — | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | ||||||||||||||||||||||||||||||||||
Cash dividends (a) | — | — | — | ( | — | ( | ||||||||||||||||||||||||||||||||
Net income | — | — | — | — | ||||||||||||||||||||||||||||||||||
Balance, March 31, 2023 | $ | $ | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||||||||||||
(a) Cash dividends declared were $ | ||||||||||||||||||||||||||||||||||||||
(b) As a result of the adoption of ASU 2022-02, we recorded a one-time cumulative increase to retained earnings, net of tax. See Note 3 of the Notes to the Consolidated Financial Statements in Part II - Item 8 of our Annual Report for additional information on the adoption of ASU 2022-02. | ||||||||||||||||||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||
(dollars in millions) | 2024 | 2023 | ||||||||||||
Cash flows from operating activities | ||||||||||||||
Net income | $ | $ | ||||||||||||
Reconciling adjustments: | ||||||||||||||
Provision for finance receivable losses | ||||||||||||||
Depreciation and amortization | ||||||||||||||
Deferred income tax charge | ||||||||||||||
Share-based compensation expense, net of forfeitures | ||||||||||||||
Gain on sales of finance receivables | ( | ( | ||||||||||||
Other | ( | ( | ||||||||||||
Cash flows due to changes in other assets and other liabilities | ( | ( | ||||||||||||
Net cash provided by operating activities | ||||||||||||||
Cash flows from investing activities | ||||||||||||||
Net principal originations and purchases of finance receivables | ( | ( | ||||||||||||
Proceeds from sales of finance receivables | ||||||||||||||
Available-for-sale securities purchased | ( | ( | ||||||||||||
Available-for-sale securities called, sold, and matured | ||||||||||||||
Other securities purchased | ( | ( | ||||||||||||
Other securities called, sold, and matured | ||||||||||||||
Other, net | ( | ( | ||||||||||||
Net cash used for investing activities | ( | ( | ||||||||||||
Cash flows from financing activities | ||||||||||||||
Proceeds from issuance and borrowings of long-term debt, net of issuance costs | ( | |||||||||||||
Repayments and repurchases of long-term debt | ( | ( | ||||||||||||
Cash dividends | ( | ( | ||||||||||||
Common stock repurchased | ( | ( | ||||||||||||
Treasury stock issued | ||||||||||||||
Withholding tax on share-based compensation | ( | ( | ||||||||||||
Net cash used for financing activities | ( | ( | ||||||||||||
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents | ( | |||||||||||||
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period | ||||||||||||||
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period | $ | $ | ||||||||||||
Supplemental cash flow information | ||||||||||||||
Cash and cash equivalents | $ | $ | ||||||||||||
Restricted cash and restricted cash equivalents | ||||||||||||||
Total cash and cash equivalents and restricted cash and restricted cash equivalents | $ | $ | ||||||||||||
(dollars in millions, except par value amount) | March 31, 2024 | December 31, 2023 | ||||||||||||
Assets | ||||||||||||||
Cash and cash equivalents | $ | $ | ||||||||||||
Investment securities (includes available-for-sale securities with a fair value and an amortized cost basis of $ | ||||||||||||||
Net finance receivables (includes loans of consolidated VIEs of $ | ||||||||||||||
Unearned insurance premium and claim reserves | ( | ( | ||||||||||||
Allowance for finance receivable losses (includes allowance of consolidated VIEs of $ | ( | ( | ||||||||||||
Net finance receivables, less unearned insurance premium and claim reserves and allowance for finance receivable losses | ||||||||||||||
Restricted cash and restricted cash equivalents (includes restricted cash and restricted cash equivalents of consolidated VIEs of $ | ||||||||||||||
Goodwill | ||||||||||||||
Other intangible assets | ||||||||||||||
Other assets | ||||||||||||||
Total assets | $ | $ | ||||||||||||
Liabilities and Shareholder’s Equity | ||||||||||||||
Long-term debt (includes debt of consolidated VIEs of $ | $ | $ | ||||||||||||
Insurance claims and policyholder liabilities | ||||||||||||||
Deferred and accrued taxes | ||||||||||||||
Other liabilities (includes other liabilities of consolidated VIEs of $ | ||||||||||||||
Total liabilities | ||||||||||||||
Contingencies (Note 12) | ||||||||||||||
Shareholder’s equity: | ||||||||||||||
Common stock, par value $ and outstanding at March 31, 2024 and December 31, 2023 | ||||||||||||||
Additional paid-in capital | ||||||||||||||
Accumulated other comprehensive loss | ( | ( | ||||||||||||
Retained earnings | ||||||||||||||
Total shareholder’s equity | ||||||||||||||
Total liabilities and shareholder’s equity | $ | $ |
Three Months Ended March 31, | ||||||||||||||
(dollars in millions) | 2024 | 2023 | ||||||||||||
Interest income | $ | $ | ||||||||||||
Interest expense | ||||||||||||||
Net interest income | ||||||||||||||
Provision for finance receivable losses | ||||||||||||||
Net interest income after provision for finance receivable losses | ||||||||||||||
Other revenues: | ||||||||||||||
Insurance | ||||||||||||||
Investment | ||||||||||||||
Gain on sales of finance receivables | ||||||||||||||
Other | ||||||||||||||
Total other revenues | ||||||||||||||
Other expenses: | ||||||||||||||
Salaries and benefits | ||||||||||||||
Other operating expenses | ||||||||||||||
Insurance policy benefits and claims | ||||||||||||||
Total other expenses | ||||||||||||||
Income before income taxes | ||||||||||||||
Income taxes | ||||||||||||||
Net income | $ | $ |
Three Months Ended March 31, | ||||||||||||||
(dollars in millions) | 2024 | 2023 | ||||||||||||
Net income | $ | $ | ||||||||||||
Other comprehensive income (loss): | ||||||||||||||
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities | ( | |||||||||||||
Foreign currency translation adjustments | ( | |||||||||||||
Changes in discount rate for insurance claims and policyholder liabilities | ||||||||||||||
Other | ( | |||||||||||||
Income tax effect: | ||||||||||||||
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities | ( | |||||||||||||
Foreign currency translation adjustments | ||||||||||||||
Changes in discount rate for insurance claims and policyholder liabilities | ( | ( | ||||||||||||
Other comprehensive income (loss), net of tax | ( | |||||||||||||
Comprehensive income | $ | $ |
OneMain Finance Corporation Shareholder's Equity | ||||||||||||||||||||||||||||||||
(dollars in millions) | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income (Loss) | Retained Earnings | Total Shareholder’s Equity | |||||||||||||||||||||||||||
Three Months Ended March 31, 2024 | ||||||||||||||||||||||||||||||||
Balance, January 1, 2024 | $ | $ | $ | ( | $ | $ | ||||||||||||||||||||||||||
Share-based compensation expense, net of forfeitures | — | — | — | |||||||||||||||||||||||||||||
Withholding tax on share-based compensation | — | ( | — | — | ( | |||||||||||||||||||||||||||
Other comprehensive loss | — | — | ( | — | ( | |||||||||||||||||||||||||||
Cash dividends | — | — | — | ( | ( | |||||||||||||||||||||||||||
Net income | — | — | — | |||||||||||||||||||||||||||||
Balance, March 31, 2024 | $ | $ | $ | ( | $ | $ | ||||||||||||||||||||||||||
Three Months Ended March 31, 2023 | ||||||||||||||||||||||||||||||||
Balance, January 1, 2023 | $ | $ | $ | ( | $ | $ | ||||||||||||||||||||||||||
— | — | — | ||||||||||||||||||||||||||||||
Balance, January 1, 2023 (post-adoption) | ( | |||||||||||||||||||||||||||||||
Share-based compensation expense, net of forfeitures | — | — | — | |||||||||||||||||||||||||||||
Withholding tax on share-based compensation | — | ( | — | — | ( | |||||||||||||||||||||||||||
Other comprehensive income | — | — | — | |||||||||||||||||||||||||||||
Cash dividends | — | — | — | ( | ( | |||||||||||||||||||||||||||
Net income | — | — | — | |||||||||||||||||||||||||||||
Balance, March 31, 2023 | $ | $ | $ | ( | $ | $ | ||||||||||||||||||||||||||
* As a result of the adoption of ASU 2022-02, we recorded a one-time cumulative increase to retained earnings, net of tax. See Note 3 of the Notes to the Consolidated Financial Statements in Part II - Item 8 of our Annual Report for additional information on the adoption of ASU 2022-02. | ||||||||||||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||
(dollars in millions) | 2024 | 2023 | ||||||||||||
Cash flows from operating activities | ||||||||||||||
Net income | $ | $ | ||||||||||||
Reconciling adjustments: | ||||||||||||||
Provision for finance receivable losses | ||||||||||||||
Depreciation and amortization | ||||||||||||||
Deferred income tax charge | ||||||||||||||
Share-based compensation expense, net of forfeitures | ||||||||||||||
Gain on sales of finance receivables | ( | ( | ||||||||||||
Other | ( | ( | ||||||||||||
Cash flows due to changes in other assets and other liabilities | ( | ( | ||||||||||||
Net cash provided by operating activities | ||||||||||||||
Cash flows from investing activities | ||||||||||||||
Net principal originations and purchases of finance receivables | ( | ( | ||||||||||||
Proceeds from sales of finance receivables | ||||||||||||||
Available-for-sale securities purchased | ( | ( | ||||||||||||
Available-for-sale securities called, sold, and matured | ||||||||||||||
Other securities purchased | ( | ( | ||||||||||||
Other securities called, sold, and matured | ||||||||||||||
Other, net | ( | ( | ||||||||||||
Net cash used for investing activities | ( | ( | ||||||||||||
Cash flows from financing activities | ||||||||||||||
Proceeds from issuance and borrowings of long-term debt, net of issuance costs | ( | |||||||||||||
Repayments and repurchases of long-term debt | ( | ( | ||||||||||||
Cash dividends | ( | ( | ||||||||||||
Withholding tax on share-based compensation | ( | ( | ||||||||||||
Net cash used for financing activities | ( | ( | ||||||||||||
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents | ( | |||||||||||||
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period | ||||||||||||||
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period | $ | $ | ||||||||||||
Supplemental cash flow information | ||||||||||||||
Cash and cash equivalents | $ | $ | ||||||||||||
Restricted cash and restricted cash equivalents | ||||||||||||||
Total cash and cash equivalents and restricted cash and restricted cash equivalents | $ | $ | ||||||||||||
1. Business and Basis of Presentation |
2. Recent Accounting Pronouncements |
3. Finance Receivables |
Consumer Loans | ||||||||||||||||||||||||||||||||
(dollars in millions) | Personal Loans | Auto Finance | Total Consumer Loans | Credit Cards | Total | |||||||||||||||||||||||||||
March 31, 2024 | ||||||||||||||||||||||||||||||||
Gross finance receivables * | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Unearned fees | ( | ( | ( | ( | ||||||||||||||||||||||||||||
Accrued finance charges and fees | ||||||||||||||||||||||||||||||||
Deferred origination costs | ||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
December 31, 2023 | ||||||||||||||||||||||||||||||||
Gross finance receivables * | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Unearned fees | ( | ( | ( | ( | ||||||||||||||||||||||||||||
Accrued finance charges and fees | ||||||||||||||||||||||||||||||||
Deferred origination costs | ||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ |
(dollars in millions) | 2024 | 2023 | 2022 | 2021 | 2020 | Prior | Total | |||||||||||||||||||||||||||||||||||||
March 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||
Performing | ||||||||||||||||||||||||||||||||||||||||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
30-59 days past due | ||||||||||||||||||||||||||||||||||||||||||||
60-89 days past due | ||||||||||||||||||||||||||||||||||||||||||||
Total performing | ||||||||||||||||||||||||||||||||||||||||||||
Nonperforming (Nonaccrual) | ||||||||||||||||||||||||||||||||||||||||||||
90+ days past due | ||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
Gross charge-offs * | $ | $ | $ | $ | $ | $ | $ |
(dollars in millions) | 2023 | 2022 | 2021 | 2020 | 2019 | Prior | Total | |||||||||||||||||||||||||||||||||||||
December 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||
Performing | ||||||||||||||||||||||||||||||||||||||||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
30-59 days past due | ||||||||||||||||||||||||||||||||||||||||||||
60-89 days past due | ||||||||||||||||||||||||||||||||||||||||||||
Total performing | ||||||||||||||||||||||||||||||||||||||||||||
Nonperforming (Nonaccrual) | ||||||||||||||||||||||||||||||||||||||||||||
90+ days past due | ||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
Gross charge-offs * | $ | $ | $ | $ | $ | $ | $ |
(dollars in millions) | 2024 | 2023 | 2022 | 2021 | 2020 | Prior | Total | |||||||||||||||||||||||||||||||||||||
March 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||
Performing | ||||||||||||||||||||||||||||||||||||||||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
30-59 days past due | ||||||||||||||||||||||||||||||||||||||||||||
60-89 days past due | ||||||||||||||||||||||||||||||||||||||||||||
Total performing | ||||||||||||||||||||||||||||||||||||||||||||
Nonperforming (Nonaccrual) | ||||||||||||||||||||||||||||||||||||||||||||
90+ days past due | ||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
Gross charge-offs * | $ | $ | $ | $ | $ | $ | $ |
(dollars in millions) | 2023 | 2022 | 2021 | 2020 | 2019 | Prior | Total | |||||||||||||||||||||||||||||||||||||
December 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||
Performing | ||||||||||||||||||||||||||||||||||||||||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
30-59 days past due | ||||||||||||||||||||||||||||||||||||||||||||
60-89 days past due | ||||||||||||||||||||||||||||||||||||||||||||
Total performing | ||||||||||||||||||||||||||||||||||||||||||||
Nonperforming (Nonaccrual) | ||||||||||||||||||||||||||||||||||||||||||||
90+ days past due | ||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
Gross charge-offs * | $ | $ | $ | $ | $ | $ | $ |
(dollars in millions) | March 31, 2024 | December 31, 2023 | ||||||||||||
Current | $ | $ | ||||||||||||
30-59 days past due | ||||||||||||||
60-89 days past due | ||||||||||||||
90+ days past due | ||||||||||||||
Total | $ | $ | ||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
(dollars in millions) | Personal Loans | Auto Finance | Personal Loans | Auto Finance | ||||||||||||||||||||||
Interest rate reduction and term extension | $ | $ | $ | $ | ||||||||||||||||||||||
Interest rate reduction and principal forgiveness | ||||||||||||||||||||||||||
Total modifications to borrowers experiencing financial difficulties | $ | $ | $ | $ | ||||||||||||||||||||||
Modifications as a percent of net finance receivables by class | % | % | % | % | ||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
(dollars in millions) | Personal Loans | Auto Finance | Personal Loans | Auto Finance | ||||||||||||||||||||||
Net finance receivables | ||||||||||||||||||||||||||
Weighted-average interest rate reduction | % | % | % | % | ||||||||||||||||||||||
Weighted-average term extension (months) | ||||||||||||||||||||||||||
Principal/interest forgiveness | $ | $ | $ | $ |
March 31, 2024* | March 31, 2023 | |||||||||||||||||||||||||
(dollars in millions) | Personal Loans | Auto Finance | Personal Loans | Auto Finance | ||||||||||||||||||||||
Current | $ | $ | $ | $ | ||||||||||||||||||||||
30-59 days past due | ||||||||||||||||||||||||||
60-89 days past due | ||||||||||||||||||||||||||
90+ days past due | ||||||||||||||||||||||||||
Total | $ | $ | $ | $ | ||||||||||||||||||||||
Three Months Ended March 31, 2024 | ||||||||||||||
(dollars in millions) | Personal Loans | Auto Finance | ||||||||||||
Interest rate reduction and term extension | $ | $ | ||||||||||||
Interest rate reduction and principal forgiveness | ||||||||||||||
Total * | $ | $ |
4. Allowance for Finance Receivable Losses |
(dollars in millions) | Consumer Loans | Credit Cards | Total | |||||||||||||||||
Three Months Ended March 31, 2024 | ||||||||||||||||||||
Balance at beginning of period | $ | $ | $ | |||||||||||||||||
Provision for finance receivable losses | ||||||||||||||||||||
Charge-offs | ( | ( | ( | |||||||||||||||||
Recoveries | ||||||||||||||||||||
Balance at end of period | $ | $ | $ | |||||||||||||||||
Three Months Ended March 31, 2023 | ||||||||||||||||||||
Balance at beginning of period | $ | $ | $ | |||||||||||||||||
Impact of adoption of ASU 2022-02 * | ( | ( | ||||||||||||||||||
Provision for finance receivable losses | ||||||||||||||||||||
Charge-offs | ( | ( | ( | |||||||||||||||||
Recoveries | ||||||||||||||||||||
Balance at end of period | $ | $ | $ | |||||||||||||||||
5. Investment Securities |
(dollars in millions) | Cost/ Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value | ||||||||||||||||||||||
March 31, 2024* | ||||||||||||||||||||||||||
Fixed maturity available-for-sale securities: | ||||||||||||||||||||||||||
U.S. government and government sponsored entities | $ | $ | $ | ( | $ | |||||||||||||||||||||
Obligations of states, municipalities, and political subdivisions | ( | |||||||||||||||||||||||||
Commercial paper | ||||||||||||||||||||||||||
Non-U.S. government and government sponsored entities | ( | |||||||||||||||||||||||||
Corporate debt | ( | |||||||||||||||||||||||||
Mortgage-backed, asset-backed, and collateralized: | ||||||||||||||||||||||||||
RMBS | ( | |||||||||||||||||||||||||
CMBS | ( | |||||||||||||||||||||||||
CDO/ABS | ( | |||||||||||||||||||||||||
Total | $ | $ | $ | ( | $ | |||||||||||||||||||||
December 31, 2023* | ||||||||||||||||||||||||||
Fixed maturity available-for-sale securities: | ||||||||||||||||||||||||||
U.S. government and government sponsored entities | $ | $ | $ | ( | $ | |||||||||||||||||||||
Obligations of states, municipalities, and political subdivisions | ( | |||||||||||||||||||||||||
Commercial paper | ||||||||||||||||||||||||||
Non-U.S. government and government sponsored entities | ( | |||||||||||||||||||||||||
Corporate debt | ( | |||||||||||||||||||||||||
Mortgage-backed, asset-backed, and collateralized: | ||||||||||||||||||||||||||
RMBS | ( | |||||||||||||||||||||||||
CMBS | ( | |||||||||||||||||||||||||
CDO/ABS | ( | |||||||||||||||||||||||||
Total | $ | $ | $ | ( | $ | |||||||||||||||||||||
Less Than 12 Months | 12 Months or Longer | Total | ||||||||||||||||||||||||||||||||||||
(dollars in millions) | Fair Value | Unrealized Losses * | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | ||||||||||||||||||||||||||||||||
March 31, 2024 | ||||||||||||||||||||||||||||||||||||||
U.S. government and government sponsored entities | $ | $ | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||||||
Obligations of states, municipalities, and political subdivisions | ( | ( | ||||||||||||||||||||||||||||||||||||
Commercial paper | ||||||||||||||||||||||||||||||||||||||
Non-U.S. government and government sponsored entities | ( | ( | ||||||||||||||||||||||||||||||||||||
Corporate debt | ( | ( | ||||||||||||||||||||||||||||||||||||
Mortgage-backed, asset-backed, and collateralized: | ||||||||||||||||||||||||||||||||||||||
RMBS | ( | ( | ||||||||||||||||||||||||||||||||||||
CMBS | ( | ( | ||||||||||||||||||||||||||||||||||||
CDO/ABS | ( | ( | ||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||||||
December 31, 2023 | ||||||||||||||||||||||||||||||||||||||
U.S. government and government sponsored entities | $ | $ | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||||||
Obligations of states, municipalities, and political subdivisions | ( | ( | ||||||||||||||||||||||||||||||||||||
Commercial paper | ||||||||||||||||||||||||||||||||||||||
Non-U.S. government and government sponsored entities | ( | ( | ||||||||||||||||||||||||||||||||||||
Corporate debt | ( | ( | ||||||||||||||||||||||||||||||||||||
Mortgage-backed, asset-backed, and collateralized: | ||||||||||||||||||||||||||||||||||||||
RMBS | ( | ( | ||||||||||||||||||||||||||||||||||||
CMBS | ( | ( | ||||||||||||||||||||||||||||||||||||
CDO/ABS | ( | ( | ||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | ( | $ | $ | ( |
(dollars in millions) | Fair Value | Amortized Cost | ||||||||||||
Fixed maturities, excluding mortgage-backed, asset-backed, and collateralized securities: | ||||||||||||||
Due in 1 year or less | $ | $ | ||||||||||||
Due after 1 year through 5 years | ||||||||||||||
Due after 5 years through 10 years | ||||||||||||||
Due after 10 years | ||||||||||||||
Mortgage-backed, asset-backed, and collateralized securities | ||||||||||||||
Total | $ | $ |
(dollars in millions) | March 31, 2024 | December 31, 2023 | ||||||||||||
Fixed maturity other securities: | ||||||||||||||
Bonds | $ | $ | ||||||||||||
Preferred stock | ||||||||||||||
Common stock | ||||||||||||||
Total | $ | $ |
6. Long-term Debt |
Senior Debt | |||||||||||||||||||||||||||||||||||
(dollars in millions) | Securitizations | Private Secured Term Funding | Revolving Conduit Facilities | Unsecured Notes (a) | Junior Subordinated Debt (a) | Total | |||||||||||||||||||||||||||||
Interest rates (b) | % | % | |||||||||||||||||||||||||||||||||
Remainder of 2024 | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
2025 | |||||||||||||||||||||||||||||||||||
2026 | |||||||||||||||||||||||||||||||||||
2027 | |||||||||||||||||||||||||||||||||||
2028 | |||||||||||||||||||||||||||||||||||
2029-2067 | |||||||||||||||||||||||||||||||||||
Secured (c) | — | — | |||||||||||||||||||||||||||||||||
Total principal maturities | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Total carrying amount | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Debt issuance costs (d) | ( | ( | ( |
7. Variable Interest Entities |
(dollars in millions) | March 31, 2024 | December 31, 2023 | ||||||||||||
Assets | ||||||||||||||
Cash and cash equivalents | $ | $ | ||||||||||||
Net finance receivables | ||||||||||||||
Allowance for finance receivable losses | ||||||||||||||
Restricted cash and restricted cash equivalents | ||||||||||||||
Other assets | ||||||||||||||
Liabilities | ||||||||||||||
Long-term debt | $ | $ | ||||||||||||
Other liabilities |
8. Insurance |
At or for the Three Months Ended March 31, | ||||||||||||||
(dollars in millions) | 2024 | 2023 | ||||||||||||
Balance at beginning of period | $ | $ | ||||||||||||
Less reinsurance recoverables | ( | ( | ||||||||||||
Net balance at beginning of period | ||||||||||||||
Additions for losses and loss adjustment expenses incurred to: | ||||||||||||||
Current year | ||||||||||||||
Prior years * | ( | ( | ||||||||||||
Total | ||||||||||||||
Reductions for losses and loss adjustment expenses paid related to: | ||||||||||||||
Current year | ( | ( | ||||||||||||
Prior years | ( | ( | ||||||||||||
Total | ( | ( | ||||||||||||
Net balance at end of period | ||||||||||||||
Plus reinsurance recoverables | ||||||||||||||
Balance at end of period | $ | $ |
At or for the Three Months Ended March 31, | ||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
(dollars in millions) | Term and Whole Life | Accidental Death and Disability Protection | Term and Whole Life | Accidental Death and Disability Protection | ||||||||||||||||||||||
Balance at beginning of period | $ | $ | $ | $ | ||||||||||||||||||||||
Effect of cumulative changes in discount rate assumptions (beginning of period) | ( | ( | ||||||||||||||||||||||||
Beginning balance at original discount rate | ||||||||||||||||||||||||||
Effect of actual variances from expected experience | ( | ( | ||||||||||||||||||||||||
Adjusted balance at beginning of period | ||||||||||||||||||||||||||
Interest accretion | ||||||||||||||||||||||||||
Net premiums collected | ( | ( | ( | ( | ||||||||||||||||||||||
Ending balance at original discount rate | ||||||||||||||||||||||||||
Effect of changes in discount rate assumptions | ( | |||||||||||||||||||||||||
Balance at ending of period | $ | $ | $ | $ |
At or for the Three Months Ended March 31, | ||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
(dollars in millions) | Term and Whole Life | Accidental Death and Disability Protection | Term and Whole Life | Accidental Death and Disability Protection | ||||||||||||||||||||||
Balance at beginning of period | $ | $ | $ | $ | ||||||||||||||||||||||
Effect of cumulative changes in discount rate assumptions (beginning of period) | ( | ( | ( | |||||||||||||||||||||||
Beginning balance at original discount rate | ||||||||||||||||||||||||||
Effect of actual variances from expected experience | ( | ( | ( | |||||||||||||||||||||||
Adjusted balance at beginning of period | ||||||||||||||||||||||||||
Net issuances | ||||||||||||||||||||||||||
Interest accretion | ||||||||||||||||||||||||||
Benefit payments | ( | ( | ( | ( | ||||||||||||||||||||||
Ending balance at original discount rate | ||||||||||||||||||||||||||
Effect of changes in discount rate assumptions | ( | |||||||||||||||||||||||||
Balance at ending of period | $ | $ | $ | $ |
At or for the Three Months Ended March 31, | ||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
(dollars in millions) | Term and Whole Life | Accidental Death and Disability Protection | Term and Whole Life | Accidental Death and Disability Protection | ||||||||||||||||||||||
Net liability for future policy benefits | $ | $ | $ | $ | ||||||||||||||||||||||
Deferred profit liability | ||||||||||||||||||||||||||
Total net liability for future policy benefits | $ | $ | $ | $ |
At or for the Three Months Ended March 31, | ||||||||||||||
(dollars in millions) | 2024 | 2023 | ||||||||||||
Term and whole life | $ | $ | ||||||||||||
Accidental death and disability protection | ||||||||||||||
Other* | ||||||||||||||
Total | $ | $ |
At or for the Three Months Ended March 31, | ||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
(dollars in millions) | Term and Whole Life | Accidental Death and Disability Protection | Term and Whole Life | Accidental Death and Disability Protection | ||||||||||||||||||||||
Expected future gross premiums: | ||||||||||||||||||||||||||
Undiscounted | $ | $ | $ | $ | ||||||||||||||||||||||
Discounted | ||||||||||||||||||||||||||
Expected future benefit payments: | ||||||||||||||||||||||||||
Undiscounted | ||||||||||||||||||||||||||
Discounted |
At or for the Three Months Ended March 31, | ||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
(dollars in millions) | Term and Whole Life | Accidental Death and Disability Protection | Term and Whole Life | Accidental Death and Disability Protection | ||||||||||||||||||||||
Gross premiums or assessments | $ | $ | $ | $ | ||||||||||||||||||||||
Interest accretion | $ | $ | $ | $ | ||||||||||||||||||||||
At or for the Three Months Ended March 31, | ||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
Term and Whole Life | Accidental Death and Disability Protection | Term and Whole Life | Accidental Death and Disability Protection | |||||||||||||||||||||||
Mortality/Morbidity: | ||||||||||||||||||||||||||
Expected | % | % | % | % | ||||||||||||||||||||||
Actual | % | % | % | % | ||||||||||||||||||||||
Lapses: | ||||||||||||||||||||||||||
Expected | % | % | % | % | ||||||||||||||||||||||
Actual | % | % | % | % |
At or for the Three Months Ended March 31, | ||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
Term and Whole Life | Accidental Death and Disability Protection | Term and Whole Life | Accidental Death and Disability Protection | |||||||||||||||||||||||
Interest accretion rate | % | % | % | % | ||||||||||||||||||||||
Current discount rate | % | % | % | % |
9. Capital Stock and Earnings Per Share (OMH Only) |
Three Months Ended March 31, | ||||||||||||||
2024 | 2023 | |||||||||||||
Balance at beginning of period | ||||||||||||||
Common stock issued | ||||||||||||||
Common stock repurchased | ( | ( | ||||||||||||
Treasury stock issued | ||||||||||||||
Balance at end of period |
Three Months Ended March 31, | ||||||||||||||
(dollars in millions, except per share data) | 2024 | 2023 | ||||||||||||
Numerator (basic and diluted): | ||||||||||||||
Net income | $ | $ | ||||||||||||
Denominator: | ||||||||||||||
Weighted average number of shares outstanding (basic) | ||||||||||||||
Effect of dilutive securities * | ||||||||||||||
Weighted average number of shares outstanding (diluted) | ||||||||||||||
Earnings per share: | ||||||||||||||
Basic | $ | $ | ||||||||||||
Diluted | $ | $ |
10. Accumulated Other Comprehensive Income (Loss) |
(dollars in millions) | Unrealized Gains (Losses) Available-for-Sale Securities (a) | Retirement Plan Liabilities Adjustments | Foreign Currency Translation Adjustments | Changes in discount rate for insurance claims and policyholder liabilities | Other (b) | Total Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||||||||||||||||||
Three Months Ended March 31, 2024 | ||||||||||||||||||||||||||||||||||||||
Balance at beginning of period | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | ( | |||||||||||||||||||||||||||
Other comprehensive income (loss) before reclassifications | ( | ( | ( | |||||||||||||||||||||||||||||||||||
Balance at end of period | $ | ( | $ | ( | $ | ( | $ | $ | $ | ( | ||||||||||||||||||||||||||||
Three Months Ended March 31, 2023 | ||||||||||||||||||||||||||||||||||||||
Balance at beginning of period | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | ( | |||||||||||||||||||||||||||
Other comprehensive income (loss) before reclassifications | ( | |||||||||||||||||||||||||||||||||||||
Balance at end of period | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | ( | |||||||||||||||||||||||||||
11. Income Taxes |
12. Contingencies |
13. Segment Information |
(dollars in millions) | Consumer and Insurance | Other | Segment to GAAP Adjustment | Consolidated Total | ||||||||||||||||||||||
Three Months Ended March 31, 2024 | ||||||||||||||||||||||||||
Interest income | $ | $ | $ | $ | ||||||||||||||||||||||
Interest expense | ||||||||||||||||||||||||||
Provision for finance receivable losses | ||||||||||||||||||||||||||
Net interest income after provision for finance receivable losses | ||||||||||||||||||||||||||
Other revenues | ||||||||||||||||||||||||||
Other expenses | ( | |||||||||||||||||||||||||
Income (loss) before income tax expense (benefit) | $ | $ | $ | $ | ||||||||||||||||||||||
Assets | $ | $ | $ | $ | ||||||||||||||||||||||
Three Months Ended March 31, 2023 | ||||||||||||||||||||||||||
Interest income | $ | $ | $ | $ | ||||||||||||||||||||||
Interest expense | ||||||||||||||||||||||||||
Provision for finance receivable losses | ||||||||||||||||||||||||||
Net interest income after provision for finance receivable losses | ||||||||||||||||||||||||||
Other revenues | ||||||||||||||||||||||||||
Other expenses | ||||||||||||||||||||||||||
Income before income tax expense | $ | $ | ( | $ | $ | |||||||||||||||||||||
Assets | $ | $ | $ | $ |
14. Fair Value Measurements |
Fair Value Measurements Using | Total Fair Value | Total Carrying Value | ||||||||||||||||||||||||||||||
(dollars in millions) | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||||||
March 31, 2024 | ||||||||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||||||
Cash and cash equivalents | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Investment securities | ||||||||||||||||||||||||||||||||
Net finance receivables, less allowance for finance receivable losses | ||||||||||||||||||||||||||||||||
Restricted cash and restricted cash equivalents | ||||||||||||||||||||||||||||||||
Other assets * | ||||||||||||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||||||||
Long-term debt | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
December 31, 2023 | ||||||||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||||||
Cash and cash equivalents | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Investment securities | ||||||||||||||||||||||||||||||||
Net finance receivables, less allowance for finance receivable losses | ||||||||||||||||||||||||||||||||
Restricted cash and restricted cash equivalents | ||||||||||||||||||||||||||||||||
Other assets * | ||||||||||||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||||||||
Long-term debt | $ | $ | $ | $ | $ |
Fair Value Measurements Using | Total Carried At Fair Value | |||||||||||||||||||||||||
(dollars in millions) | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||
March 31, 2024 | ||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Cash equivalents in mutual funds | $ | $ | $ | $ | ||||||||||||||||||||||
Cash equivalents in securities | ||||||||||||||||||||||||||
Investment securities: | ||||||||||||||||||||||||||
Available-for-sale securities | ||||||||||||||||||||||||||
U.S. government and government sponsored entities | ||||||||||||||||||||||||||
Obligations of states, municipalities, and political subdivisions | ||||||||||||||||||||||||||
Commercial paper | ||||||||||||||||||||||||||
Non-U.S. government and government sponsored entities | ||||||||||||||||||||||||||
Corporate debt | ||||||||||||||||||||||||||
RMBS | ||||||||||||||||||||||||||
CMBS | ||||||||||||||||||||||||||
CDO/ABS | ||||||||||||||||||||||||||
Total available-for-sale securities | ||||||||||||||||||||||||||
Other securities | ||||||||||||||||||||||||||
Bonds: | ||||||||||||||||||||||||||
Corporate debt | ||||||||||||||||||||||||||
CDO/ABS | ||||||||||||||||||||||||||
Total bonds | ||||||||||||||||||||||||||
Preferred stock | ||||||||||||||||||||||||||
Common stock | ||||||||||||||||||||||||||
Total other securities | ||||||||||||||||||||||||||
Total investment securities | ||||||||||||||||||||||||||
Restricted cash equivalents in mutual funds | ||||||||||||||||||||||||||
Restricted cash equivalents in securities | ||||||||||||||||||||||||||
Total | $ | $ | $ | $ |
Fair Value Measurements Using | Total Carried At Fair Value | |||||||||||||||||||||||||
(dollars in millions) | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||
December 31, 2023 | ||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Cash equivalents in mutual funds | $ | $ | $ | $ | ||||||||||||||||||||||
Investment securities: | ||||||||||||||||||||||||||
Available-for-sale securities | ||||||||||||||||||||||||||
U.S. government and government sponsored entities | ||||||||||||||||||||||||||
Obligations of states, municipalities, and political subdivisions | ||||||||||||||||||||||||||
Commercial paper | ||||||||||||||||||||||||||
Non-U.S. government and government sponsored entities | ||||||||||||||||||||||||||
Corporate debt | ||||||||||||||||||||||||||
RMBS | ||||||||||||||||||||||||||
CMBS | ||||||||||||||||||||||||||
CDO/ABS | ||||||||||||||||||||||||||
Total available-for-sale securities | ||||||||||||||||||||||||||
Other securities | ||||||||||||||||||||||||||
Bonds: | ||||||||||||||||||||||||||
Corporate debt | ||||||||||||||||||||||||||
CDO/ABS | ||||||||||||||||||||||||||
Total bonds | ||||||||||||||||||||||||||
Preferred stock | ||||||||||||||||||||||||||
Common stock | ||||||||||||||||||||||||||
Total other securities | ||||||||||||||||||||||||||
Total investment securities | ||||||||||||||||||||||||||
Restricted cash equivalents in mutual funds | ||||||||||||||||||||||||||
Total | $ | $ | $ | $ |
15. Subsequent Events |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
Topic | Page | |||||||
Forward-Looking Statements |
Overview |
Recent Developments and Outlook |
Results of Operations |
At or for the Three Months Ended March 31, | ||||||||||||||
(dollars in millions, except per share amounts) | 2024 | 2023 | ||||||||||||
Interest income | $ | 1,173 | $ | 1,094 | ||||||||||
Interest expense | 277 | 239 | ||||||||||||
Provision for finance receivable losses | 431 | 385 | ||||||||||||
Net interest income after provision for finance receivable losses | 465 | 470 | ||||||||||||
Other revenues | 180 | 177 | ||||||||||||
Other expenses | 441 | 412 | ||||||||||||
Income before income taxes | 204 | 235 | ||||||||||||
Income taxes | 49 | 56 | ||||||||||||
Net income | $ | 155 | $ | 179 | ||||||||||
Share Data: | ||||||||||||||
Earnings per share: | ||||||||||||||
Diluted | $ | 1.29 | $ | 1.48 | ||||||||||
Selected Financial Statistics * | ||||||||||||||
Total finance receivables: | ||||||||||||||
Net finance receivables | $ | 21,083 | $ | 19,809 | ||||||||||
Average net receivables | $ | 21,267 | $ | 19,881 | ||||||||||
Gross charge-off ratio | 10.12 | % | 9.21 | % | ||||||||||
Recovery ratio | (1.46) | % | (1.41) | % | ||||||||||
Net charge-off ratio | 8.66 | % | 7.80 | % | ||||||||||
* See “Glossary” at the beginning of this report for formulas and definitions of our key performance ratios. | ||||||||||||||
At or for the Three Months Ended March 31, | ||||||||||||||
(dollars in millions, except per share amounts) | 2024 | 2023 | ||||||||||||
Selected Financial Statistics * | ||||||||||||||
Personal loans: | ||||||||||||||
Net finance receivables | $ | 19,854 | $ | 19,229 | ||||||||||
Origination volume | $ | 2,354 | $ | 2,704 | ||||||||||
Number of accounts | 2,320,733 | 2,269,336 | ||||||||||||
Number of accounts originated | 230,850 | 263,370 | ||||||||||||
Auto finance: | ||||||||||||||
Net finance receivables | $ | 843 | $ | 458 | ||||||||||
Origination volume | $ | 168 | $ | 113 | ||||||||||
Number of accounts | 61,911 | 33,942 | ||||||||||||
Number of accounts originated | 10,359 | 7,302 | ||||||||||||
Consumer loans: | ||||||||||||||
Net finance receivables | $ | 20,697 | $ | 19,687 | ||||||||||
Yield | 22.12 | % | 22.27 | % | ||||||||||
Origination volume | $ | 2,523 | $ | 2,817 | ||||||||||
Number of accounts | 2,382,644 | 2,303,278 | ||||||||||||
Number of accounts originated | 241,209 | 270,672 | ||||||||||||
Net charge-off ratio | 8.58 | % | 7.72 | % | ||||||||||
30-89 Delinquency ratio | 2.72 | % | 2.58 | % | ||||||||||
Credit cards: | ||||||||||||||
Net finance receivables | $ | 386 | $ | 122 | ||||||||||
Purchase volume | $ | 168 | $ | 53 | ||||||||||
Number of open accounts | 508,608 | 160,508 | ||||||||||||
Debt balances: | ||||||||||||||
Long-term debt balance | $ | 19,520 | $ | 18,206 | ||||||||||
Average daily debt balance | $ | 19,702 | $ | 18,355 |
Three Months Ended March 31, | ||||||||||||||
(dollars in millions) | 2024 | 2023 | ||||||||||||
Consumer and Insurance | ||||||||||||||
Income before income taxes - Segment Accounting Basis | $ | 203 | $ | 236 | ||||||||||
Adjustments: | ||||||||||||||
Restructuring charges | 27 | — | ||||||||||||
Net loss on repurchases and repayments of debt | 2 | — | ||||||||||||
Acquisition-related transaction and integration expenses | 1 | — | ||||||||||||
Adjusted pretax income (non-GAAP) | 233 | 236 | ||||||||||||
Provision for finance receivable losses | 431 | 385 | ||||||||||||
Net charge-offs | (457) | (382) | ||||||||||||
Pretax capital generation (non-GAAP) | $ | 207 | $ | 239 | ||||||||||
Segment Results |
At or for the Three Months Ended March 31, | ||||||||||||||
(dollars in millions) | 2024 | 2023 | ||||||||||||
Interest income | $ | 1,172 | $ | 1,092 | ||||||||||
Interest expense | 276 | 238 | ||||||||||||
Provision for finance receivable losses | 431 | 385 | ||||||||||||
Net interest income after provision for finance receivable losses | 465 | 469 | ||||||||||||
Other revenues | 180 | 176 | ||||||||||||
Other expenses | 412 | 409 | ||||||||||||
Adjusted pretax income (non-GAAP) | $ | 233 | $ | 236 | ||||||||||
Selected Financial Statistics * | ||||||||||||||
Total finance receivables: | ||||||||||||||
Net finance receivables | $ | 21,083 | $ | 19,810 | ||||||||||
Average net receivables | $ | 21,267 | $ | 19,882 | ||||||||||
Gross charge-off ratio | 10.12 | % | 9.21 | % | ||||||||||
Recovery ratio | (1.46) | % | (1.41) | % | ||||||||||
Net charge-off ratio | 8.66 | % | 7.80 | % | ||||||||||
* See “Glossary” at the beginning of this report for formulas and definitions of our key performance ratios. | ||||||||||||||
At or for the Three Months Ended March 31, | ||||||||||||||
(dollars in millions) | 2024 | 2023 | ||||||||||||
Selected Financial Statistics * | ||||||||||||||
Personal loans: | ||||||||||||||
Net finance receivables | $ | 19,854 | $ | 19,230 | ||||||||||
Origination volume | $ | 2,354 | $ | 2,704 | ||||||||||
Number of accounts | 2,320,733 | 2,269,336 | ||||||||||||
Number of accounts originated | 230,850 | 263,370 | ||||||||||||
Auto finance: | ||||||||||||||
Net finance receivables | $ | 843 | $ | 458 | ||||||||||
Origination volume | $ | 168 | $ | 113 | ||||||||||
Number of accounts | 61,911 | 33,942 | ||||||||||||
Number of accounts originated | 10,359 | 7,302 | ||||||||||||
Consumer loans: | ||||||||||||||
Net finance receivables | $ | 20,697 | $ | 19,688 | ||||||||||
Yield | 22.12 | % | 22.26 | % | ||||||||||
Origination volume | $ | 2,523 | $ | 2,817 | ||||||||||
Number of accounts | 2,382,644 | 2,303,278 | ||||||||||||
Number of accounts originated | 241,209 | 270,672 | ||||||||||||
Net charge-off ratio | 8.58 | % | 7.72 | % | ||||||||||
30-89 Delinquency ratio | 2.72 | % | 2.58 | % | ||||||||||
Credit cards: | ||||||||||||||
Net finance receivables | $ | 386 | $ | 122 | ||||||||||
Purchase volume | $ | 168 | $ | 53 | ||||||||||
Number of open accounts | 508,608 | 160,508 | ||||||||||||
Credit Quality |
Consumer and Insurance | ||||||||||||||
(dollars in millions) | Consumer Loans | Credit Cards | ||||||||||||
March 31, 2024 | ||||||||||||||
Current | $ | 19,544 | $ | 343 | ||||||||||
30-89 days past due | 562 | 19 | ||||||||||||
90+ days past due | 591 | 24 | ||||||||||||
Total net finance receivables | $ | 20,697 | $ | 386 | ||||||||||
Delinquency ratio | ||||||||||||||
30-89 days past due | 2.72 | % | 4.99 | % | ||||||||||
30+ days past due | 5.57 | % | 11.28 | % | ||||||||||
90+ days past due | 2.86 | % | 6.30 | % | ||||||||||
December 31, 2023 | ||||||||||||||
Current | $ | 19,725 | $ | 297 | ||||||||||
30-89 days past due | 689 | 16 | ||||||||||||
90+ days past due | 605 | 17 | ||||||||||||
Total net finance receivables | $ | 21,019 | $ | 330 | ||||||||||
Delinquency ratio | ||||||||||||||
30-89 days past due | 3.28 | % | 4.93 | % | ||||||||||
30+ days past due | 6.16 | % | 9.96 | % | ||||||||||
90+ days past due | 2.88 | % | 5.03 | % |
(dollars in millions) | Consumer and Insurance | Segment to GAAP Adjustment | Consolidated Total | |||||||||||||||||||||||
Consumer Loans | Credit Cards | |||||||||||||||||||||||||
Three Months Ended March 31, 2024 | ||||||||||||||||||||||||||
Balance at beginning of period | $ | 2,415 | $ | 65 | $ | — | $ | 2,480 | ||||||||||||||||||
Provision for finance receivable losses | 406 | 25 | — | 431 | ||||||||||||||||||||||
Charge-offs | (522) | (12) | — | (534) | ||||||||||||||||||||||
Recoveries | 77 | — | — | 77 | ||||||||||||||||||||||
Balance at end of period | $ | 2,376 | $ | 78 | $ | — | $ | 2,454 | ||||||||||||||||||
Net finance receivables | $ | 20,697 | $ | 386 | $ | — | $ | 21,083 | ||||||||||||||||||
Allowance ratio | 11.48 | % | 20.21 | % | (b) | 11.64 | % | |||||||||||||||||||
Three Months Ended March 31, 2023 | ||||||||||||||||||||||||||
Balance at beginning of period | $ | 2,294 | $ | 21 | $ | (4) | $ | 2,311 | ||||||||||||||||||
Impact of adoption of ASU 2022-02 (a) | (20) | — | 4 | (16) | ||||||||||||||||||||||
Provision for finance receivable losses | 377 | 8 | — | 385 | ||||||||||||||||||||||
Charge-offs | (445) | (6) | — | (451) | ||||||||||||||||||||||
Recoveries | 69 | — | — | 69 | ||||||||||||||||||||||
Balance at end of period | $ | 2,275 | $ | 23 | $ | — | $ | 2,298 | ||||||||||||||||||
Net finance receivables | $ | 19,688 | $ | 122 | $ | (1) | $ | 19,809 | ||||||||||||||||||
Allowance ratio | 11.55 | % | 19.25 | % | (b) | 11.60 | % | |||||||||||||||||||
Liquidity and Capital Resources |
As of March 31, 2024 | Rating | Outlook | ||||||||||||
S&P | BB | Stable | ||||||||||||
Moody’s | Ba2 | Stable | ||||||||||||
KBRA | BB+ | Positive |
Declaration Date | Record Date | Payment Date | Dividend Per Share | Amount Paid | ||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
February 7, 2024 | February 20, 2024 | February 23, 2024 | $ | 1.00 | $ | 120 | ||||||||||||||||||||
Total | $ | 1.00 | $ | 120 |
(dollars in millions) | Issue Amount (a) | Initial Collateral Balance | Current Note Amounts Outstanding (a) | Current Collateral Balance (b) | Current Weighted Average Interest Rate | Original Revolving Period | ||||||||||||||||||||||||||||||||
OMFIT 2018-2 | $ | 368 | $ | 381 | $ | 166 | $ | 193 | 4.20 | % | 5 years | |||||||||||||||||||||||||||
OMFIT 2019-2 | 900 | 947 | 900 | 995 | 3.30 | % | 7 years | |||||||||||||||||||||||||||||||
OMFIT 2019-A | 789 | 892 | 750 | 892 | 3.78 | % | 7 years | |||||||||||||||||||||||||||||||
OMFIT 2020-2 | 1,000 | 1,053 | 1,000 | 1,053 | 2.03 | % | 5 years | |||||||||||||||||||||||||||||||
OMFIT 2021-1 | 850 | 904 | 850 | 904 | 2.81 | % | 5 years | |||||||||||||||||||||||||||||||
OMFIT 2022-S1 | 600 | 652 | 600 | 652 | 4.31 | % | 3 years | |||||||||||||||||||||||||||||||
OMFIT 2022-2 | 1,000 | 1,099 | 1,000 | 1,099 | 5.17 | % | 2 years | |||||||||||||||||||||||||||||||
OMFIT 2022-3 | 979 | 1,090 | 796 | 1,090 | 6.00 | % | 2 years | |||||||||||||||||||||||||||||||
OMFIT 2023-1 | 825 | 920 | 825 | 920 | 5.82 | % | 5 years | |||||||||||||||||||||||||||||||
OMFIT 2023-2 | 1,400 | 1,566 | 1,400 | 1,566 | 6.44 | % | 3 years | |||||||||||||||||||||||||||||||
ODART 2019-1 | 737 | 750 | 700 | 722 | 3.79 | % | 5 years | |||||||||||||||||||||||||||||||
ODART 2021-1 | 1,000 | 1,053 | 775 | 787 | 1.01 | % | 2 years | |||||||||||||||||||||||||||||||
ODART 2022-1 | 600 | 632 | 600 | 632 | 5.09 | % | 2 years | |||||||||||||||||||||||||||||||
ODART 2023-1 | 750 | 792 | 750 | 792 | 5.63 | % | 3 years | |||||||||||||||||||||||||||||||
Total securitizations | $ | 11,798 | $ | 12,731 | $ | 11,112 | $ | 12,297 |
(dollars in millions) | Advance Maximum Balance | Amount Drawn | ||||||||||||
OneMain Financial Funding VII, LLC | $ | 600 | $ | — | ||||||||||
OneMain Financial Auto Funding I, LLC | 550 | — | ||||||||||||
Seine River Funding, LLC | 550 | — | ||||||||||||
Hudson River Funding, LLC | 500 | — | ||||||||||||
OneMain Financial Funding XI, LLC | 425 | — | ||||||||||||
OneMain Financial Funding VIII, LLC | 400 | — | ||||||||||||
River Thames Funding, LLC | 400 | — | ||||||||||||
OneMain Financial Funding X, LLC | 400 | — | ||||||||||||
OneMain Financial Funding XII, LLC | 400 | — | ||||||||||||
Chicago River Funding, LLC | 375 | — | ||||||||||||
Mystic River Funding, LLC | 350 | — | ||||||||||||
Thayer Brook Funding, LLC | 350 | 1 | ||||||||||||
Columbia River Funding, LLC | 350 | — | ||||||||||||
Hubbard River Funding, LLC | 250 | — | ||||||||||||
New River Funding Trust | 250 | — | ||||||||||||
St. Lawrence River Funding, LLC | 250 | — | ||||||||||||
Total | $ | 6,400 | $ | 1 |
(dollars in millions) | Advance Maximum Balance | Amount Drawn | ||||||||||||
OneMain Financial Credit Card Trust – Series 2024-VFN1 | $ | 150 | $ | — | ||||||||||
OneMain Financial Credit Card Trust – Series 2024-VFN2 | 150 | — | ||||||||||||
Total | $ | 300 | $ | — |
Critical Accounting Policies and Estimates |
Recent Accounting Pronouncements |
Seasonality |
Item 3. Quantitative and Qualitative Disclosures About Market Risk. |
Item 4. Controls and Procedures. |
Item 1. Legal Proceedings. |
Item 1A. Risk Factors. |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
Period | Total Number of Shares Purchased | Average Price paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (a) | Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (a) | ||||||||||||||||||||||
January 1 - January 31 | — | $ | — | — | $ | 660,499,429 | ||||||||||||||||||||
February 1 - February 29 | 16,056 | 46.69 | 16,056 | 659,749,718 | ||||||||||||||||||||||
March 1 - March 31 | 92,629 | 48.47 | 92,629 | 655,260,337 | ||||||||||||||||||||||
Total | 108,685 | $ | 48.20 | 108,685 | ||||||||||||||||||||||
Item 3. Defaults Upon Senior Securities. |
Item 4. Mine Safety Disclosures. |
Item 5. Other Information. |
Item 6. Exhibit Index. |
Exhibit Number | Description | |||||||
101 | Interactive data files pursuant to Rule 405 of Regulation S-T, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Shareholder’s Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to the Condensed Consolidated Financial Statements. | |||||||
104 | Cover Page Interactive Data File in Inline XBRL format (Included in Exhibit 101). |
OMH Signature |
ONEMAIN HOLDINGS, INC. | ||||||||||||||
(Registrant) | ||||||||||||||
Date: | May 1, 2024 | By: | /s/ Jeannette E. Osterhout | |||||||||||
Jeannette E. Osterhout | ||||||||||||||
Executive Vice President and Chief Financial Officer | ||||||||||||||
(Duly Authorized Officer and Principal Financial Officer) |
OMFC Signature |
ONEMAIN FINANCE CORPORATION | ||||||||||||||
(Registrant) | ||||||||||||||
Date: | May 1, 2024 | By: | /s/ Matthew W. Vaughan | |||||||||||
Matthew W. Vaughan | ||||||||||||||
Vice President - Senior Managing Director and Chief Financial Officer | ||||||||||||||
(Duly Authorized Officer and Principal Financial Officer) |
Exhibit 31.1 |
Date: | May 1, 2024 | ||||||||||
/s/ Douglas H. Shulman | |||||||||||
Douglas H. Shulman | |||||||||||
President and Chief Executive Officer |
Exhibit 31.2 |
Date: | May 1, 2024 | ||||||||||
/s/ Jeannette E. Osterhout | |||||||||||
Jeannette E. Osterhout | |||||||||||
Executive Vice President and Chief Financial Officer | |||||||||||
(Duly Authorized Officer and Principal Financial Officer) |
Exhibit 31.3 |
Date: | May 1, 2024 | ||||||||||
/s/ Jeannette E. Osterhout | |||||||||||
Jeannette E. Osterhout | |||||||||||
President and Chief Executive Officer |
Exhibit 31.4 |
Date: | May 1, 2024 | ||||||||||
/s/ Matthew W. Vaughan | |||||||||||
Matthew W. Vaughan | |||||||||||
Vice President - Senior Managing Director and Chief Financial Officer | |||||||||||
(Duly Authorized Officer and Principal Financial Officer) |
Exhibit 32.1 |
/s/ Douglas H. Shulman | |||||||||||
Douglas H. Shulman | |||||||||||
President and Chief Executive Officer | |||||||||||
/s/ Jeannette E. Osterhout | |||||||||||
Jeannette E. Osterhout | |||||||||||
Executive Vice President and Chief Financial Officer | |||||||||||
Date: | May 1, 2024 |
Exhibit 32.2 |
/s/ Jeannette E. Osterhout | |||||||||||
Jeannette E. Osterhout | |||||||||||
President and Chief Executive Officer | |||||||||||
/s/ Matthew W. Vaughan | |||||||||||
Matthew W. Vaughan | |||||||||||
Vice President - Senior Managing Director and Chief Financial Officer | |||||||||||
Date: | May 1, 2024 |
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
|||
---|---|---|---|---|---|
Investment securities, fair value | $ 1,618 | $ 1,647 | |||
Investment securities, amortized cost basis | 1,743 | 1,765 | |||
Net finance receivables | 21,083 | 21,349 | |||
Financing receivable, allowance for credit loss | 2,454 | 2,480 | |||
Restricted cash and restricted cash equivalents | 599 | [1] | 534 | ||
Long-term debt | 19,520 | 19,813 | |||
Other liabilities | $ 543 | $ 671 | |||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | |||
Common stock, shares authorized (in shares) | 2,000,000,000 | 2,000,000,000 | |||
Common stock, shares issued (in shares) | 119,877,252 | 119,757,277 | |||
Common stock, shares outstanding (in shares) | 119,877,252 | 119,757,277 | |||
Treasury stock at cost (in shares) | 15,475,531 | 15,383,804 | |||
Consolidated VIEs | |||||
Net finance receivables | $ 12,641 | $ 12,780 | |||
Financing receivable, allowance for credit loss | 1,429 | 1,428 | |||
Restricted cash and restricted cash equivalents | 576 | 523 | |||
Long-term debt | 11,420 | 11,579 | |||
Other liabilities | $ 26 | $ 26 | |||
|
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Income Statement [Abstract] | ||
Interest income | $ 1,173 | $ 1,094 |
Interest expense | 277 | 239 |
Net interest income | 896 | 855 |
Provision for finance receivable losses | 431 | 385 |
Net interest income after provision for finance receivable losses | 465 | 470 |
Other revenues: | ||
Insurance | 112 | 111 |
Investment | 32 | 25 |
Gain on sales of finance receivables | 6 | 17 |
Other | 30 | 24 |
Total other revenues | 180 | 177 |
Other expenses: | ||
Salaries and benefits | 224 | 212 |
Other operating expenses | 167 | 153 |
Insurance policy benefits and claims | 50 | 47 |
Total other expenses | 441 | 412 |
Income before income taxes | 204 | 235 |
Income taxes | 49 | 56 |
Net income | $ 155 | $ 179 |
Weighted average number of shares outstanding: | ||
Basic (in shares) | 119,829,174 | 120,765,661 |
Diluted (in shares) | 120,244,669 | 120,969,891 |
Earnings per share: | ||
Basic (in dollars per share) | $ 1.29 | $ 1.48 |
Diluted (in dollars per share) | $ 1.29 | $ 1.48 |
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 155 | $ 179 |
Other comprehensive income (loss): | ||
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities | (8) | 24 |
Foreign currency translation adjustments | (4) | 0 |
Changes in discount rate for insurance claims and policyholder liabilities | 7 | 4 |
Other | 0 | (3) |
Income tax effect: | ||
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities | 2 | (5) |
Foreign currency translation adjustments | 1 | 0 |
Changes in discount rate for insurance claims and policyholder liabilities | (2) | (1) |
Other comprehensive income (loss), net of tax | (4) | 19 |
Comprehensive income | $ 151 | $ 198 |
Condensed Consolidated Statements of Shareholder's Equity (Unaudited) - USD ($) $ in Millions |
Total |
Net impact of adoption of ASU 2022-02 |
[1] | Cumulative Effect, Period Of Adoption, Adjusted Balance |
Common Stock |
Common Stock
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
Additional Paid-in Capital |
Additional Paid-in Capital
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
Accumulated Other Comprehensive Income (Loss) |
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
Retained Earnings |
Retained Earnings
Net impact of adoption of ASU 2022-02
|
[1] |
Retained Earnings
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
Treasury Stock |
Treasury Stock
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance at beginning of period at Dec. 31, 2022 | $ 3,015 | $ 12 | $ 3,027 | $ 1 | $ 1 | $ 1,689 | $ 1,689 | $ (127) | $ (127) | $ 2,119 | $ 12 | $ 2,131 | $ (667) | $ (667) | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||
Common stock repurchased | (27) | (27) | ||||||||||||||||||
Treasury stock issued | 1 | 1 | ||||||||||||||||||
Share-based compensation expense, net of forfeitures | 12 | 12 | ||||||||||||||||||
Withholding tax on share-based compensation | (8) | (8) | ||||||||||||||||||
Other comprehensive income (loss) | 19 | 19 | ||||||||||||||||||
Cash dividends | [2] | (122) | (122) | |||||||||||||||||
Net income | 179 | 179 | ||||||||||||||||||
Balance at end of period at Mar. 31, 2023 | 3,081 | 1 | 1,693 | (108) | 2,188 | (693) | ||||||||||||||
Balance at beginning of period at Dec. 31, 2023 | 3,186 | 1 | 1,715 | (87) | 2,285 | (728) | ||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||
Common stock repurchased | (5) | (5) | ||||||||||||||||||
Treasury stock issued | 1 | 1 | ||||||||||||||||||
Share-based compensation expense, net of forfeitures | 11 | 11 | ||||||||||||||||||
Withholding tax on share-based compensation | (8) | (8) | ||||||||||||||||||
Other comprehensive income (loss) | (4) | (4) | ||||||||||||||||||
Cash dividends | [2] | (122) | (122) | |||||||||||||||||
Net income | 155 | 155 | ||||||||||||||||||
Balance at end of period at Mar. 31, 2024 | $ 3,214 | $ 1 | $ 1,718 | $ (91) | $ 2,318 | $ (732) | ||||||||||||||
|
Condensed Consolidated Statements of Shareholder's Equity (Unaudited) (Parenthetical) - $ / shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Statement of Stockholders' Equity [Abstract] | ||
Dividends declared (in dollars per share) | $ 1.00 | $ 1.00 |
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|||
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] | ||||
Net income | $ 155 | $ 179 | ||
Reconciling adjustments: | ||||
Provision for finance receivable losses | 431 | 385 | ||
Depreciation and amortization | 66 | 61 | ||
Deferred income tax charge | 15 | 9 | ||
Share-based compensation expense, net of forfeitures | 11 | 12 | ||
Gain on sales of finance receivables | (6) | (17) | ||
Other | (1) | (1) | ||
Cash flows due to changes in other assets and other liabilities | (113) | (66) | ||
Net cash provided by operating activities | 558 | 562 | ||
Cash flows from investing activities | ||||
Net principal originations and purchases of finance receivables | (345) | (432) | ||
Proceeds from sales of finance receivables | 117 | 200 | ||
Available-for-sale securities purchased | (64) | (44) | ||
Available-for-sale securities called, sold, and matured | 78 | 88 | ||
Other securities purchased | (4) | (2) | ||
Other securities called, sold, and matured | 5 | 2 | ||
Other, net | (20) | (16) | ||
Net cash used for investing activities | (233) | (204) | ||
Cash flows from financing activities | ||||
Proceeds from issuance and borrowings of long-term debt, net of issuance costs | 843 | |||
Payments for debt issuance costs | (6) | |||
Repayments of long-term debt | 303 | 928 | ||
Cash dividends | (122) | (123) | ||
Common stock repurchased | (5) | (27) | ||
Treasury stock issued | 1 | 1 | ||
Withholding tax on share-based compensation | (8) | (8) | ||
Net cash used for financing activities | (443) | (242) | ||
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents | (118) | 116 | ||
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period | 1,548 | 959 | ||
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period | 1,430 | 1,075 | ||
Supplemental cash flow information | ||||
Cash and cash equivalents | 831 | 544 | ||
Restricted cash and restricted cash equivalents | [1] | 599 | 531 | |
Total cash and cash equivalents and restricted cash and restricted cash equivalents | $ 1,430 | $ 1,075 | ||
|
Condensed Consolidated Balance Sheets (Unaudited) - OMFC - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
|||||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash and cash equivalents | $ 831 | $ 1,014 | |||||
Investment securities (includes available-for-sale securities with a fair value and an amortized cost basis of $1.6 billion and $1.7 billion in 2024, respectively, and $1.6 billion and $1.8 billion in 2023, respectively) | 1,691 | 1,719 | |||||
Net finance receivables (includes loans of consolidated VIEs of $12.6 billion in 2024 and $12.8 billion in 2023) | 21,083 | 21,349 | |||||
Unearned insurance premium and claim reserves | (749) | (771) | |||||
Allowance for finance receivable losses (includes allowance of consolidated VIEs of $1.4 billion in 2024 and 2023) | (2,454) | (2,480) | |||||
Net finance receivables, less unearned insurance premium and claim reserves and allowance for finance receivable losses | 17,880 | 18,098 | |||||
Restricted cash and restricted cash equivalents (includes restricted cash and restricted cash equivalents of consolidated VIEs of $576 million in 2024 and $523 million in 2023) | 599 | [1] | 534 | ||||
Goodwill | 1,437 | 1,437 | |||||
Other intangible assets | 259 | 260 | |||||
Other assets | 1,211 | 1,232 | |||||
Total assets | 23,908 | 24,294 | |||||
Liabilities and Shareholders’ Equity | |||||||
Long-term debt (includes debt of consolidated VIEs of $11.4 billion in 2024 and $11.6 billion in 2023) | 19,520 | 19,813 | |||||
Insurance claims and policyholder liabilities | 597 | 615 | |||||
Deferred and accrued taxes | 34 | 9 | |||||
Other liabilities (includes other liabilities of consolidated VIEs of $26 million in 2024 and 2023) | 543 | 671 | |||||
Total liabilities | 20,694 | 21,108 | |||||
Contingencies (Note 12) | |||||||
Shareholders’ equity: | |||||||
Common stock, par value $0.50 per share; 25,000,000 shares authorized, 10,160,021 shares issued and outstanding at March 31, 2024 and December 31, 2023 | 1 | 1 | |||||
Additional paid-in capital | 1,718 | 1,715 | |||||
Accumulated other comprehensive loss | (91) | (87) | |||||
Retained earnings | 2,318 | 2,285 | |||||
Total shareholders’ equity | 3,214 | 3,186 | |||||
Total liabilities and shareholders’ equity | 23,908 | 24,294 | |||||
Consolidated VIEs | |||||||
Assets | |||||||
Cash and cash equivalents | 3 | 2 | |||||
Net finance receivables (includes loans of consolidated VIEs of $12.6 billion in 2024 and $12.8 billion in 2023) | 12,641 | 12,780 | |||||
Allowance for finance receivable losses (includes allowance of consolidated VIEs of $1.4 billion in 2024 and 2023) | (1,429) | (1,428) | |||||
Restricted cash and restricted cash equivalents (includes restricted cash and restricted cash equivalents of consolidated VIEs of $576 million in 2024 and $523 million in 2023) | 576 | 523 | |||||
Other assets | 36 | 32 | |||||
Liabilities and Shareholders’ Equity | |||||||
Long-term debt (includes debt of consolidated VIEs of $11.4 billion in 2024 and $11.6 billion in 2023) | 11,420 | 11,579 | |||||
Other liabilities (includes other liabilities of consolidated VIEs of $26 million in 2024 and 2023) | 26 | 26 | |||||
OMFC | |||||||
Assets | |||||||
Cash and cash equivalents | 812 | 1,011 | |||||
Investment securities (includes available-for-sale securities with a fair value and an amortized cost basis of $1.6 billion and $1.7 billion in 2024, respectively, and $1.6 billion and $1.8 billion in 2023, respectively) | 1,691 | 1,719 | |||||
Net finance receivables (includes loans of consolidated VIEs of $12.6 billion in 2024 and $12.8 billion in 2023) | 21,083 | 21,349 | |||||
Unearned insurance premium and claim reserves | (749) | (771) | |||||
Allowance for finance receivable losses (includes allowance of consolidated VIEs of $1.4 billion in 2024 and 2023) | (2,454) | (2,480) | |||||
Net finance receivables, less unearned insurance premium and claim reserves and allowance for finance receivable losses | 17,880 | 18,098 | |||||
Restricted cash and restricted cash equivalents (includes restricted cash and restricted cash equivalents of consolidated VIEs of $576 million in 2024 and $523 million in 2023) | 599 | [2] | 534 | ||||
Goodwill | 1,437 | 1,437 | |||||
Other intangible assets | 259 | 260 | |||||
Other assets | 1,211 | 1,230 | |||||
Total assets | 23,889 | 24,289 | |||||
Liabilities and Shareholders’ Equity | |||||||
Long-term debt (includes debt of consolidated VIEs of $11.4 billion in 2024 and $11.6 billion in 2023) | 19,520 | 19,813 | |||||
Insurance claims and policyholder liabilities | 597 | 615 | |||||
Deferred and accrued taxes | 35 | 9 | |||||
Other liabilities (includes other liabilities of consolidated VIEs of $26 million in 2024 and 2023) | 543 | 672 | |||||
Total liabilities | 20,695 | 21,109 | |||||
Contingencies (Note 12) | |||||||
Shareholders’ equity: | |||||||
Common stock, par value $0.50 per share; 25,000,000 shares authorized, 10,160,021 shares issued and outstanding at March 31, 2024 and December 31, 2023 | 5 | 5 | |||||
Additional paid-in capital | 1,962 | 1,959 | |||||
Accumulated other comprehensive loss | (91) | (87) | |||||
Retained earnings | 1,318 | 1,303 | |||||
Total shareholders’ equity | 3,194 | 3,180 | |||||
Total liabilities and shareholders’ equity | 23,889 | 24,289 | |||||
OMFC | Consolidated VIEs | |||||||
Assets | |||||||
Net finance receivables (includes loans of consolidated VIEs of $12.6 billion in 2024 and $12.8 billion in 2023) | 12,600 | 12,800 | |||||
Allowance for finance receivable losses (includes allowance of consolidated VIEs of $1.4 billion in 2024 and 2023) | (1,400) | (1,400) | |||||
Restricted cash and restricted cash equivalents (includes restricted cash and restricted cash equivalents of consolidated VIEs of $576 million in 2024 and $523 million in 2023) | 576 | 523 | |||||
Liabilities and Shareholders’ Equity | |||||||
Long-term debt (includes debt of consolidated VIEs of $11.4 billion in 2024 and $11.6 billion in 2023) | 11,400 | 11,600 | |||||
Other liabilities (includes other liabilities of consolidated VIEs of $26 million in 2024 and 2023) | $ 26 | $ 26 | |||||
|
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - OMFC - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
|||||
---|---|---|---|---|---|---|---|
Investment securities, fair value | $ 1,618 | $ 1,647 | |||||
Investment securities, amortized cost basis | 1,743 | 1,765 | |||||
Net finance receivables | 21,083 | 21,349 | |||||
Financing receivable, allowance for credit loss | 2,454 | 2,480 | |||||
Restricted cash and restricted cash equivalents | 599 | [1] | 534 | ||||
Long-term debt | 19,520 | 19,813 | |||||
Other liabilities | $ 543 | $ 671 | |||||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | |||||
Common stock, shares authorized (in shares) | 2,000,000,000 | 2,000,000,000 | |||||
Common stock, shares issued (in shares) | 119,877,252 | 119,757,277 | |||||
Common stock, shares outstanding (in shares) | 119,877,252 | 119,757,277 | |||||
OMFC | |||||||
Investment securities, fair value | $ 1,600 | $ 1,600 | |||||
Investment securities, amortized cost basis | 1,700 | 1,800 | |||||
Net finance receivables | 21,083 | 21,349 | |||||
Financing receivable, allowance for credit loss | 2,454 | 2,480 | |||||
Restricted cash and restricted cash equivalents | 599 | [2] | 534 | ||||
Long-term debt | 19,520 | 19,813 | |||||
Other liabilities | $ 543 | $ 672 | |||||
Common stock, par value (in dollars per share) | $ 0.50 | $ 0.50 | |||||
Common stock, shares authorized (in shares) | 25,000,000 | 25,000,000 | |||||
Common stock, shares issued (in shares) | 10,160,021 | 10,160,021 | |||||
Common stock, shares outstanding (in shares) | 10,160,021 | 10,160,021 | |||||
Consolidated VIEs | |||||||
Net finance receivables | $ 12,641 | $ 12,780 | |||||
Financing receivable, allowance for credit loss | 1,429 | 1,428 | |||||
Restricted cash and restricted cash equivalents | 576 | 523 | |||||
Long-term debt | 11,420 | 11,579 | |||||
Other liabilities | 26 | 26 | |||||
Consolidated VIEs | OMFC | |||||||
Net finance receivables | 12,600 | 12,800 | |||||
Financing receivable, allowance for credit loss | 1,400 | 1,400 | |||||
Restricted cash and restricted cash equivalents | 576 | 523 | |||||
Long-term debt | 11,400 | 11,600 | |||||
Other liabilities | $ 26 | $ 26 | |||||
|
Condensed Consolidated Statements of Operations (Unaudited) - OMFC - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Interest income | $ 1,173 | $ 1,094 |
Interest expense | 277 | 239 |
Net interest income | 896 | 855 |
Provision for finance receivable losses | 431 | 385 |
Net interest income after provision for finance receivable losses | 465 | 470 |
Other revenues: | ||
Insurance | 112 | 111 |
Investment | 32 | 25 |
Gain on sales of finance receivables | 6 | 17 |
Other | 30 | 24 |
Total other revenues | 180 | 177 |
Other expenses: | ||
Salaries and benefits | 224 | 212 |
Other operating expenses | 167 | 153 |
Insurance policy benefits and claims | 50 | 47 |
Total other expenses | 441 | 412 |
Income before income taxes | 204 | 235 |
Income taxes | 49 | 56 |
Net income | 155 | 179 |
OMFC | ||
Interest income | 1,173 | 1,094 |
Interest expense | 277 | 239 |
Net interest income | 896 | 855 |
Provision for finance receivable losses | 431 | 385 |
Net interest income after provision for finance receivable losses | 465 | 470 |
Other revenues: | ||
Insurance | 112 | 111 |
Investment | 32 | 25 |
Gain on sales of finance receivables | 6 | 17 |
Other | 30 | 24 |
Total other revenues | 180 | 177 |
Other expenses: | ||
Salaries and benefits | 224 | 212 |
Other operating expenses | 167 | 153 |
Insurance policy benefits and claims | 50 | 47 |
Total other expenses | 441 | 412 |
Income before income taxes | 204 | 235 |
Income taxes | 49 | 56 |
Net income | $ 155 | $ 179 |
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - OMFC - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Net income | $ 155 | $ 179 |
Other comprehensive income (loss): | ||
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities | (8) | 24 |
Foreign currency translation adjustments | (4) | 0 |
Changes in discount rate for insurance claims and policyholder liabilities | 7 | 4 |
Other | 0 | (3) |
Income tax effect: | ||
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities | 2 | (5) |
Foreign currency translation adjustments | 1 | 0 |
Changes in discount rate for insurance claims and policyholder liabilities | (2) | (1) |
Other comprehensive income (loss), net of tax | (4) | 19 |
Comprehensive income | 151 | 198 |
OMFC | ||
Net income | 155 | 179 |
Other comprehensive income (loss): | ||
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities | (8) | 24 |
Foreign currency translation adjustments | (4) | 0 |
Changes in discount rate for insurance claims and policyholder liabilities | 7 | 4 |
Other | 0 | (3) |
Income tax effect: | ||
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities | 2 | (5) |
Foreign currency translation adjustments | 1 | 0 |
Changes in discount rate for insurance claims and policyholder liabilities | (2) | (1) |
Other comprehensive income (loss), net of tax | (4) | 19 |
Comprehensive income | $ 151 | $ 198 |
Condensed Consolidated Statements of Shareholder's Equity (Unaudited) - OMFC - USD ($) $ in Millions |
Total |
Net impact of adoption of ASU 2022-02 |
[1] | Cumulative Effect, Period Of Adoption, Adjusted Balance |
Common Stock |
Common Stock
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
Additional Paid-in Capital |
Additional Paid-in Capital
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
Accumulated Other Comprehensive Income (Loss) |
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
Retained Earnings |
Retained Earnings
Net impact of adoption of ASU 2022-02
|
[1] |
Retained Earnings
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
OMFC |
OMFC
Net impact of adoption of ASU 2022-02
|
[2] |
OMFC
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
OMFC
Common Stock
|
OMFC
Common Stock
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
OMFC
Additional Paid-in Capital
|
OMFC
Additional Paid-in Capital
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
OMFC
Accumulated Other Comprehensive Income (Loss)
|
OMFC
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
OMFC
Retained Earnings
|
OMFC
Retained Earnings
Net impact of adoption of ASU 2022-02
|
[2] |
OMFC
Retained Earnings
Cumulative Effect, Period Of Adoption, Adjusted Balance
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance at beginning of period at Dec. 31, 2022 | $ 3,015 | $ 12 | $ 3,027 | $ 1 | $ 1 | $ 1,689 | $ 1,689 | $ (127) | $ (127) | $ 2,119 | $ 12 | $ 2,131 | $ 3,004 | $ 12 | $ 3,016 | $ 5 | $ 5 | $ 1,933 | $ 1,933 | $ (127) | $ (127) | $ 1,193 | $ 12 | $ 1,205 | ||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||||||||||||||||||
Share-based compensation expense, net of forfeitures | 12 | 12 | 12 | 12 | ||||||||||||||||||||||||||||||||
Withholding tax on share-based compensation | (8) | (8) | (8) | (8) | ||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | 19 | 19 | 19 | 19 | ||||||||||||||||||||||||||||||||
Cash dividends | (122) | [3] | (122) | [3] | (150) | (150) | ||||||||||||||||||||||||||||||
Net income | 179 | 179 | 179 | 179 | ||||||||||||||||||||||||||||||||
Balance at end of period at Mar. 31, 2023 | 3,081 | 1 | 1,693 | (108) | 2,188 | 3,068 | 5 | 1,937 | (108) | 1,234 | ||||||||||||||||||||||||||
Balance at beginning of period at Dec. 31, 2023 | 3,186 | 1 | 1,715 | (87) | 2,285 | 3,180 | 5 | 1,959 | (87) | 1,303 | ||||||||||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||||||||||||||||||
Share-based compensation expense, net of forfeitures | 11 | 11 | 11 | 11 | ||||||||||||||||||||||||||||||||
Withholding tax on share-based compensation | (8) | (8) | (8) | (8) | ||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | (4) | (4) | (4) | (4) | ||||||||||||||||||||||||||||||||
Cash dividends | (122) | [3] | (122) | [3] | (140) | (140) | ||||||||||||||||||||||||||||||
Net income | 155 | 155 | 155 | 155 | ||||||||||||||||||||||||||||||||
Balance at end of period at Mar. 31, 2024 | $ 3,214 | $ 1 | $ 1,718 | $ (91) | $ 2,318 | $ 3,194 | $ 5 | $ 1,962 | $ (91) | $ 1,318 | ||||||||||||||||||||||||||
|
Condensed Consolidated Statements of Shareholder's Equity (Unaudited) (Parenthetical) - OMFC - $ / shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Statement of Stockholders' Equity [Abstract] | ||
Dividends declared (in dollars per share) | $ 1.00 | $ 1.00 |
Condensed Consolidated Statements of Cash Flows (Unaudited) - OMFC - USD ($) $ in Millions |
3 Months Ended | |||||
---|---|---|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|||||
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] | ||||||
Net income | $ 155 | $ 179 | ||||
Reconciling adjustments: | ||||||
Provision for finance receivable losses | 431 | 385 | ||||
Depreciation and amortization | 66 | 61 | ||||
Deferred income tax charge | 15 | 9 | ||||
Share-based compensation expense, net of forfeitures | 11 | 12 | ||||
Gain on sales of finance receivables | (6) | (17) | ||||
Other | (1) | (1) | ||||
Cash flows due to changes in other assets and other liabilities | (113) | (66) | ||||
Net cash provided by operating activities | 558 | 562 | ||||
Cash flows from investing activities | ||||||
Net principal originations and purchases of finance receivables | (345) | (432) | ||||
Proceeds from sales of finance receivables | 117 | 200 | ||||
Available-for-sale securities purchased | (64) | (44) | ||||
Available-for-sale securities called, sold, and matured | 78 | 88 | ||||
Other securities purchased | (4) | (2) | ||||
Other securities called, sold, and matured | 5 | 2 | ||||
Other, net | (20) | (16) | ||||
Net cash used for investing activities | (233) | (204) | ||||
Cash flows from financing activities | ||||||
Proceeds from issuance and borrowings of long-term debt, net of issuance costs | 843 | |||||
Payments for debt issuance costs | (6) | |||||
Repayments and repurchases of long-term debt | (303) | (928) | ||||
Cash dividends | (122) | (123) | ||||
Withholding tax on share-based compensation | (8) | (8) | ||||
Net cash used for financing activities | (443) | (242) | ||||
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents | (118) | 116 | ||||
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period | 1,548 | 959 | ||||
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period | 1,430 | 1,075 | ||||
Supplemental cash flow information | ||||||
Cash and cash equivalents | 831 | 544 | ||||
Restricted cash and restricted cash equivalents | [1] | 599 | 531 | |||
Total cash and cash equivalents and restricted cash and restricted cash equivalents | 1,430 | 1,075 | ||||
OMFC | ||||||
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] | ||||||
Net income | 155 | 179 | ||||
Reconciling adjustments: | ||||||
Provision for finance receivable losses | 431 | 385 | ||||
Depreciation and amortization | 66 | 61 | ||||
Deferred income tax charge | 15 | 9 | ||||
Share-based compensation expense, net of forfeitures | 11 | 12 | ||||
Gain on sales of finance receivables | (6) | (17) | ||||
Other | (1) | (1) | ||||
Cash flows due to changes in other assets and other liabilities | (114) | (66) | ||||
Net cash provided by operating activities | 557 | 562 | ||||
Cash flows from investing activities | ||||||
Net principal originations and purchases of finance receivables | (345) | (432) | ||||
Proceeds from sales of finance receivables | 117 | 200 | ||||
Available-for-sale securities purchased | (64) | (44) | ||||
Available-for-sale securities called, sold, and matured | 78 | 88 | ||||
Other securities purchased | (4) | (2) | ||||
Other securities called, sold, and matured | 5 | 2 | ||||
Other, net | (21) | (16) | ||||
Net cash used for investing activities | (234) | (204) | ||||
Cash flows from financing activities | ||||||
Proceeds from issuance and borrowings of long-term debt, net of issuance costs | 843 | |||||
Payments for debt issuance costs | (6) | |||||
Repayments and repurchases of long-term debt | (303) | (928) | ||||
Cash dividends | (140) | (152) | ||||
Withholding tax on share-based compensation | (8) | (8) | ||||
Net cash used for financing activities | (457) | (245) | ||||
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents | (134) | 113 | ||||
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period | 1,545 | 951 | ||||
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period | 1,411 | 1,064 | ||||
Supplemental cash flow information | ||||||
Cash and cash equivalents | 812 | 533 | ||||
Restricted cash and restricted cash equivalents | [2] | 599 | 531 | |||
Total cash and cash equivalents and restricted cash and restricted cash equivalents | $ 1,411 | $ 1,064 | ||||
|
Business and Basis of Presentation |
3 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||
Business and Basis of Presentation |
OneMain Holdings, Inc. (“OMH”), and its wholly owned direct subsidiary, OneMain Finance Corporation (“OMFC”) are financial services holding companies whose subsidiaries engage in the consumer finance and insurance businesses. The results of OMFC are consolidated into the results of OMH. Due to the nominal differences between OMFC and OMH, content throughout this filing relates to both OMH and OMFC, except where otherwise indicated. OMH and OMFC are referred to in this report, collectively with their subsidiaries, whether directly or indirectly owned, as “the Company,” “OneMain,” “we,” “us,” or “our.” BASIS OF PRESENTATION We prepared our condensed consolidated financial statements using generally accepted accounting principles in the United States of America (“GAAP”). These statements are unaudited. The year-end condensed balance sheet data was derived from our audited financial statements but does not include all disclosures required by GAAP. The statements include the accounts of OMH, its wholly owned subsidiaries, and variable interest entities (“VIEs”) in which we hold a controlling financial interest and for which we are considered to be the primary beneficiary as of the financial statement date. We eliminated all material intercompany accounts and transactions. We made judgments, estimates, and assumptions that affect amounts reported in our condensed consolidated financial statements and disclosures of contingent assets and liabilities. In management’s opinion, the condensed consolidated financial statements include the normal, recurring adjustments necessary for a fair statement of results. Actual results could differ from our estimates. We evaluated the effects of and the need to disclose events that occurred subsequent to the balance sheet date. The condensed consolidated financial statements in this report should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report. We follow the same significant accounting policies for our interim reporting except for the new accounting pronouncements subsequently adopted and disclosed in Note 2. To conform to the 2024 presentation, we reclassified certain items in prior periods of our condensed consolidated financial statements.
|
Recent Accounting Pronouncements |
3 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||
Accounting Changes and Error Corrections [Abstract] | |||||||
Recent Accounting Pronouncements |
ACCOUNTING PRONOUNCEMENTS TO BE ADOPTED Segment Reporting In November of 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires annual and interim disclosure of significant segment expenses and other segment items. The amendments in this ASU will become effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied on a retrospective basis to all prior periods presented in the financial statements. We are currently evaluating the impact of the standard on our segment disclosures. Income Taxes In December of 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disaggregated information in the rate reconciliation and income taxes paid disclosures. The amendments in this ASU will become effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied on a prospective basis, with retrospective application allowed. We are currently evaluating the impact of the standard on our income tax disclosures. We do not believe that any accounting pronouncements issued, but not yet effective, would have a material impact on our consolidated financial statements or disclosures, if adopted.
|
Finance Receivables |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Finance Receivables |
Our finance receivables consist of consumer loans and credit cards. Consumer loans include personal loans and auto finance. Personal loans are non-revolving, with a fixed rate, have fixed terms generally between and six years, and are secured by automobiles, other titled collateral, or are unsecured. Auto finance includes automobile retail installment contracts originated through our dealership network. Auto finance receivables are non-revolving, with a fixed rate, have fixed terms generally between and six years, and are secured by automobiles. Credit cards are open-ended, revolving, with a fixed rate, and are unsecured. Components of our net finance receivables were as follows:
* Consumer loan gross finance receivables equal the unpaid principal balance. For precompute personal loans, unpaid principal balance is the gross contractual payments less the unaccreted balance of unearned finance charges. Credit card gross finance receivables equal the unpaid principal balance, billed interest, and fees. WHOLE LOAN SALE TRANSACTIONS We have whole loan sale flow agreements with third parties, with current terms of less than two years, in which we agreed to sell a remaining total of $630 million gross receivables of newly originated unsecured personal loans along with any associated accrued interest. These unsecured personal loans are derecognized from our balance sheet at the time of sale. We service the personal loans sold and are entitled to a servicing fee and other fees commensurate with the services performed as part of the agreements. The gain on sales and servicing fees are recorded in Other revenues in our condensed consolidated statements of operations. We sold $110 million and $180 million of gross finance receivables during the three months ended March 31, 2024 and 2023, respectively. The gain on the sales were $6 million and $17 million during the three months ended March 31, 2024 and 2023, respectively. CREDIT QUALITY INDICATOR We consider the delinquency status of our finance receivables as our key credit quality indicator. We monitor the delinquency of our finance receivable portfolio, including the migration between the delinquency buckets and changes in the delinquency trends to manage our exposure to credit risk in the portfolio. When consumer loans are 60 days contractually past due, we consider these accounts to be at an increased risk for loss and move collection of these accounts to our central collection operations. We consider our consumer loans to be nonperforming at 90 days or more contractually past due, at which point we stop accruing finance charges and reverse finance charges previously accrued. For our personal loans, we reversed net accrued finance charges of $41 million and $37 million during the three months ended March 31, 2024 and 2023, respectively. For auto finance, reversed net accrued finance charges were immaterial during the three months ended March 31, 2024 and 2023. Finance charges recognized from the contractual interest portion of payments received on nonaccrual personal loans and auto finance loans were immaterial during the three months ended March 31, 2024 and 2023. All consumer loans in nonaccrual status are considered in our estimate of allowance for finance receivable losses. We accrue finance charges and fees on credit cards until charge-off at 180 days contractually past due, at which point we reverse finance charges and fees previously accrued. For credit cards, net accrued finance charges and fees reversed were immaterial during the three months ended March 31, 2024 and 2023. The following tables below are a summary of our personal loans by the year of origination and number of days delinquent:
* Represents gross charge-offs for the three months ended March 31, 2024.
* Represents gross charge-offs for the three months ended March 31, 2023. The following tables below are a summary of our auto finance loans by the year of origination and number of days delinquent:
* Represents gross charge-offs for the three months ended March 31, 2024.
* Represents gross charge-offs for the three months ended March 31, 2023. The following is a summary of credit cards by number of days delinquent:
There were no credit cards that were converted to term loans at March 31, 2024 or December 31, 2023. UNFUNDED LENDING COMMITMENTS Our unfunded lending commitments consist of the unused credit card lines, which are unconditionally cancellable. We do not anticipate that all of our customers will access their entire available line at any given point in time. The unused credit card lines totaled $263 million and $223 million at March 31, 2024 and December 31, 2023, respectively. MODIFIED FINANCE RECEIVABLES TO BORROWERS EXPERIENCING FINANCIAL DIFFICULTY We make modifications to our finance receivables to assist borrowers who are experiencing financial difficulty and when we modify the contractual terms for economic or other reasons related to the borrower’s financial difficulties, we classify that receivable as a modified finance receivable. The following tables below represent information regarding modified finance receivables to borrowers experiencing financial difficulty on or after January 1, 2023, the effective date of ASU 2022-02. The period-end carrying value of finance receivables modified during the period were as follows:
The financial effect of modifications made during the period were as follows:
The performance of finance receivables modified within the previous 12 months by delinquency status was as follows:
* Excludes $55 million of personal loan receivables and $1 million of auto finance receivables that were modified and subsequently charged off within the previous 12 months. The period-end carrying value of finance receivables that defaulted during the period to cause the receivable to be considered nonperforming (90 days or more contractually past due) and had been modified within the 12 months preceding the default were as follows:
* There were no modified finance receivables for which there was a default during the three months ended March 31, 2023 to cause the modified finance receivable to be considered nonperforming (90 days or more past due).
|
Allowance for Finance Receivable Losses |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allowance for Finance Receivable Losses |
We establish an allowance for finance receivable losses through the provision for finance receivable losses. We evaluate our finance receivable portfolio by the level of contractual delinquency in the portfolio, specifically in the late-stage delinquency buckets and inclusive of the migration of the finance receivables through the delinquency buckets. We estimate and record an allowance for finance receivable losses to cover the expected lifetime credit losses on our finance receivables. Our allowance for finance receivable losses may fluctuate based upon changes in portfolio growth, credit quality, and economic conditions. Our methodology to estimate expected credit losses uses recent macroeconomic forecasts, which include forecasts for unemployment. We leverage projections from various industry leading providers. We also consider inflationary pressures, consumer confidence levels, and elevated interest rates that may continue to impact the economic outlook. At March 31, 2024, our economic forecast used a reasonable and supportable period of 12 months. The decrease in our allowance for finance receivable losses for the three months ended March 31, 2024 was driven by a seasonal decline in net finance receivables. We may experience further changes to the macroeconomic assumptions within our forecast, as well as changes to our loan loss performance outlook, both of which could lead to further changes in our allowance for finance receivable losses, allowance ratio, and provision for finance receivable losses. Changes in the allowance for finance receivable losses were as follows:
* As a result of the adoption of ASU 2022-02, we recorded a one-time adjustment to the allowance for finance receivable losses. See Notes 3, 4, and 5 of the Notes to the Consolidated Financial Statements in Part II - Item 8 of our Annual Report for additional information on the adoption of ASU 2022-02.
|
Investment Securities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment Securities |
AVAILABLE-FOR-SALE SECURITIES Cost/amortized cost, allowance for credit losses, unrealized gains and losses, and fair value of fixed maturity available-for-sale securities by type were as follows:
* The allowance for credit losses related to our investment securities as of March 31, 2024 and 2023 was immaterial. Interest receivables reported in Other assets in our condensed consolidated balance sheets totaled $14 million as of March 31, 2024 and December 31, 2023. There were no material amounts reversed from investment revenue for available-for-sale securities for the three months ended March 31, 2024 and 2023. Fair value and unrealized losses on available-for-sale securities by type and length of time in a continuous unrealized loss position without an allowance for credit losses were as follows:
* Unrealized losses on certain available-for-sale securities were less than $1 million and, therefore, were not quantified in the table above. On a lot basis, we had 2,036 and 1,984 investment securities in an unrealized loss position at March 31, 2024 and December 31, 2023, respectively. We do not consider the unrealized losses to be credit-related, as these unrealized losses primarily relate to changes in interest rates and market spreads subsequent to purchase. Additionally, as of March 31, 2024, there were no credit impairments on investment securities that we intend to sell. We do not have plans to sell any of the remaining investment securities with unrealized losses as of March 31, 2024, and we believe it is more likely than not that we would not be required to sell such investment securities before recovery of their amortized cost. We continue to monitor unrealized loss positions for potential credit impairments. During the three months ended March 31, 2024 and 2023, there were no material credit impairments related to our investment securities. Therefore, there were no material additions or reductions in the allowance for credit losses (impairments recognized or reversed in earnings) on credit impaired available-for-sale securities for the three months ended March 31, 2024 and 2023. The proceeds of available-for-sale securities sold or redeemed during the three months ended March 31, 2024 and 2023 totaled $19 million and $26 million, respectively. The net realized gains and losses were immaterial during the three months ended March 31, 2024 and 2023. Contractual maturities of fixed-maturity available-for-sale securities at March 31, 2024 were as follows:
Actual maturities may differ from contractual maturities since issuers and borrowers may have the right to call or prepay obligations. We may sell investment securities before maturity for general corporate and working capital purposes and to achieve certain investment strategies. The fair value of securities on deposit with third parties totaled $512 million and $524 million at March 31, 2024 and December 31, 2023, respectively. OTHER SECURITIES The fair value of other securities by type was as follows:
Net unrealized gains and losses on other securities held were immaterial for the three months ended March 31, 2024 and 2023. Net realized gains and losses on other securities sold or redeemed were immaterial for the three months ended March 31, 2024 and 2023. Other securities primarily consist of equity securities and those securities for which the fair value option was elected. We report net unrealized and realized gains and losses on other securities held, sold, or redeemed in Other revenue - investment.
|
Long-term Debt |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long-term Debt |
Principal maturities of long-term debt by type of debt at March 31, 2024 were as follows:
(a) Pursuant to the Base Indenture, the Supplemental Indentures, and the Guaranty Agreements, OMH agreed to fully and unconditionally guarantee, on a senior unsecured basis, payments of principal, premium and interest on the Unsecured Notes and Junior Subordinated Debenture. The OMH guarantees of OMFC’s long-term debt are subject to customary release provisions. (b) The interest rates shown are the range of contractual rates in effect at March 31, 2024. (c) Securitizations, private secured term funding, and borrowings under the revolving conduit facilities are not included in the above maturities by period due to their variable monthly repayments, which may result in pay-off prior to the stated maturity date. See Note 7 for further information on our long-term debt associated with securitizations, private secured term funding, and revolving conduit facilities. (d) Debt issuance costs are reported as a direct deduction from long-term debt, with the exception of debt issuance costs associated with our revolving conduit facilities, credit card revolving variable funding note (“VFN”) facilities, and unsecured corporate revolver, which totaled $38 million at March 31, 2024 and are reported in Other assets in our condensed consolidated balance sheets. UNSECURED CORPORATE REVOLVER At March 31, 2024, the total maximum borrowing capacity of our unsecured corporate revolver was $1.3 billion. The corporate revolver has a five-year term beginning October 25, 2021, during which draws and repayments may occur. Any outstanding principal balance is due and payable on October 25, 2026. At March 31, 2024, no amounts were drawn under this facility.
|
Variable Interest Entities |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variable Interest Entities |
CONSOLIDATED VIES We have transferred finance receivables to VIEs for asset-backed financing transactions and include the assets and liabilities in our condensed consolidated financial statements because we are the primary beneficiary of each VIE. We account for these asset-backed debt obligations as securitized borrowings. See Note 2 and Note 9 of the Notes to the Consolidated Financial Statements in Part II - Item 8 included in our Annual Report for more detail regarding VIEs. We parenthetically disclose on our condensed consolidated balance sheets the VIE’s assets that can only be used to settle the VIE’s obligations and liabilities when its creditors have no recourse against the primary beneficiary’s general credit. The carrying amounts of consolidated VIE assets and liabilities associated with our securitization trusts, private secured term funding, revolving conduit facilities, and credit card revolving VFN facilities were as follows:
Other than the retained subordinate and residual interests in our consolidated VIEs, we are under no further obligation than is otherwise noted herein, either contractually or implicitly, to provide financial support to these entities. Consolidated interest expense related to our VIEs totaled $138 million and $101 million during the three months ended March 31, 2024 and 2023, respectively. SECURITIZED BORROWINGS Each of our outstanding securitizations contain a revolving period ranging from to seven years during which no principal payments are required to be made on the related asset-backed notes. The indentures governing our securitized borrowings contain early amortization events and events of default, that, if triggered, may result in the acceleration of the obligation to pay principal and interest on the related asset-backed notes. CREDIT CARD REVOLVING VFN FACILITIES We have transferred credit card gross finance receivables to a master trust, OneMain Financial Credit Card Trust (“OMFCT”), and we continue to service and administer the credit cards. As of March 31, 2024, OMFCT was the issuing entity for two credit card revolving VFN facilities by way of certain indenture supplements and note purchase agreements with a total maximum borrowing capacity of $300 million. Each credit card revolving VFN facility has a revolving period during which time no principal payments are required, but may be made without penalty, followed by a subsequent amortization period. Principal balances of outstanding notes, if any, are due and payable in full over periods ranging up to six years as of March 31, 2024. Amounts drawn on these credit card revolving VFN facilities are secured and collateralized by credit card gross finance receivables. PRIVATE SECURED TERM FUNDING At March 31, 2024, an aggregate amount of $350 million was outstanding under the private secured term funding collateralized by our consumer loans. No principal payments are required to be made until after April 25, 2025, followed by a subsequent one-year amortization period, at the expiration of which the outstanding principal amount is due and payable. REVOLVING CONDUIT FACILITIES We had access to 16 revolving conduit facilities with a total maximum borrowing capacity of $6.4 billion as of March 31, 2024. Our conduit facilities contain revolving periods during which time no principal payments are required, but may be made without penalty, followed by a subsequent amortization period. Principal balances of outstanding loans, if any, are due and payable in full over periods ranging up to nine years as of March 31, 2024. Amounts drawn on these facilities are collateralized by our consumer loans.
|
Insurance |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance |
Changes in the reserve for unpaid claims and loss adjustment expenses (net of reinsurance recoverables) on our short-duration insurance contracts:
* At March 31, 2024, there was a redundancy in the prior years’ net reserves due to favorable development of collateral protection claims during the period. At March 31, 2023, there was a redundancy in the prior years’ net reserves, due to favorable development of credit disability claims during the period. LIABILITY FOR FUTURE POLICY BENEFITS The present value of expected net premiums on long-duration insurance contracts were as follows:
The present value of expected future policy benefits on long-duration insurance contracts were as follows:
The net liability for future policy benefits on long-duration insurance contracts were as follows:
The weighted-average duration of the liability for future policy benefits was 8 years at March 31, 2024 and March 31, 2023. The following table reconciles the net liability for future policy benefits to Insurance claims and policyholder liabilities in the condensed consolidated balance sheets:
* Other primarily includes reserves for short-duration contracts that are payable to third-party beneficiaries. The undiscounted and discounted expected future gross premiums and expected future benefits and expenses for our long-duration insurance contracts were as follows:
The revenue and interest accretion related to our long-duration insurance contracts recognized in the condensed consolidated statements of operations were as follows:
The expected and actual experience for mortality, morbidity, and lapses of the liability for future policy benefits were as follows:
The weighted-average interest rates for the liability of future policy benefits for our long-duration insurance contracts were as follows:
|
Capital Stock and Earnings Per Share (OMH Only) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Capital Stock and Earnings Per Share (OMH Only) |
CAPITAL STOCK OMH has two classes of authorized capital stock: preferred stock and common stock. OMFC has two classes of authorized capital stock: special stock and common stock. OMH and OMFC may issue preferred stock and special stock, respectively, in one or more series. The OMH Board of Directors and the OMFC Board of Directors determine the dividend, liquidation, redemption, conversion, voting, and other rights prior to issuance. Changes in OMH shares of common stock issued and outstanding were as follows:
EARNINGS PER SHARE (OMH ONLY) The computation of earnings per share was as follows:
* We have excluded weighted-average unvested restricted stock units totaling 728,403 and 1,543,976 for the three months ended March 31, 2024 and 2023, respectively, from the fully-diluted earnings per share calculations as these shares would be anti-dilutive, which could impact the earnings per share calculation in the future. Basic earnings per share is computed by dividing net income by the weighted-average number of shares outstanding during each period. Diluted earnings per share is computed based on the weighted-average number of shares outstanding plus the effect of potentially dilutive shares outstanding during the period using the treasury stock method. The potentially dilutive shares represent outstanding unvested restricted stock units.
|
Accumulated Other Comprehensive Income (Loss) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss) |
Changes, net of tax, in Accumulated other comprehensive income (loss) were as follows:
(a) There were no material amounts related to available-for-sale debt securities for which an allowance for credit losses was recorded during the three months ended March 31, 2024 and 2023. (b) Other primarily includes changes in the fair value of our mark-to-market derivative instruments that have been designated as cash flow hedges. Reclassification adjustments from Accumulated other comprehensive income (loss) to the applicable line item on our condensed consolidated statements of operations were immaterial for the three months ended March 31, 2024 and 2023.
|
Income Taxes |
3 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||
Income Tax Disclosure [Abstract] | |||||||
Income Taxes |
We had a net deferred tax asset of $463 million and $477 million at March 31, 2024 and December 31, 2023, respectively. We follow the guidance of ASC 740, Income Taxes, for interim reporting of income taxes under which we calculate an estimated annual effective tax rate (“AETR”) and apply the AETR to our year-to-date income (loss) before income taxes. In addition, we recognize any discrete items as they occur. The effective tax rate for the three months ended March 31, 2024 was 24.1%, compared to 24.0% for the same period in 2023. The effective tax rate for the three months ended March 31, 2024 and 2023 differed from the federal statutory rate of 21% primarily due to the effect of state income taxes. We are under examination by various states for the years 2017 to 2021. Management believes it has adequately provided for taxes for such years. Our gross unrecognized tax benefits, including related interest and penalties, totaled $11 million at March 31, 2024 and December 31, 2023. We accrue interest related to uncertain tax positions in income tax expense. The amount of any change in the balance of uncertain tax liabilities over the next 12 months is not expected to be material to our condensed consolidated financial statements.
|
Contingencies |
3 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||
Contingencies |
LEGAL CONTINGENCIES In the normal course of business, we have been named, from time to time, as defendants in various legal actions, including arbitrations, class actions, and other litigation arising in connection with our activities. Some of the actual or threatened legal actions include claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages. Additionally, we are, from time to time, in the normal course of business, subject to inquiries and investigations by federal, state and local governmental authorities regarding our products and our operations. These inquiries and investigations may result in fines, restitution or other penalties, including injunctive relief that may result in restrictions on our business. While we will continue to evaluate legal actions to determine whether a loss is reasonably possible or probable and is reasonably estimable, there can be no assurance that material losses will not be incurred from pending, threatened or future litigation, investigations, examinations, or other claims. We contest liability and/or the amount of damages, as appropriate, in each pending matter. Where available information indicates that it is probable that a liability had been incurred at the date of the condensed consolidated financial statements and we can reasonably estimate the amount of that loss, we accrue the estimated loss by a charge to income. In many actions, however, it is inherently difficult to determine whether any loss is probable or even reasonably possible, or to estimate the amount of any loss. In addition, even where loss is reasonably possible or an exposure to loss exists in excess of the liability already accrued with respect to a previously recognized loss contingency, it is not always possible to reasonably estimate the size of the possible loss or range of loss. For certain legal actions, we cannot reasonably estimate such losses, particularly for actions that are in their early stages of development or where plaintiffs seek substantial or indeterminate damages. Numerous issues may need to be resolved, including through potentially lengthy discovery and determination of important factual matters, and by addressing novel or unsettled legal questions relevant to the actions in question, before a loss or additional loss or range of loss or range of additional loss can be reasonably estimated for any given action. For certain other legal actions, we can estimate reasonably possible losses, additional losses, ranges of loss or ranges of additional loss in excess of amounts accrued, but do not believe, based on current knowledge and after consultation with counsel, that such losses will have a material adverse effect on our condensed consolidated financial statements as a whole.
|
Segment Information |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information |
At March 31, 2024, Consumer and Insurance (“C&I”) is our only reportable segment. The remaining components (which we refer to as “Other”) consist of our liquidating SpringCastle Portfolio servicing activity and our non-originating legacy operations, which primarily include our liquidating real estate loans. The accounting policies of the C&I segment are the same as those disclosed in Note 2 and Note 17 of the Notes to the Consolidated Financial Statements in Part II - Item 8 included in our Annual Report. The following tables present information about C&I and Other, as well as reconciliations to the condensed consolidated financial statement amounts.
|
Fair Value Measurements |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements |
The accounting policies of our fair value measurements are the same as those disclosed in Note 2 and Note 18 of the Notes to the Consolidated Financial Statements in Part II - Item 8 included in our Annual Report. The following table presents the carrying amounts and estimated fair values of our financial instruments and indicates the level in the fair value hierarchy of the estimated fair value measurement based on the observability of the inputs used:
*Other assets at March 31, 2024 and December 31, 2023 primarily consists of finance receivables held for sale. FAIR VALUE MEASUREMENTS — RECURRING BASIS The following tables present information about our assets measured at fair value on a recurring basis and indicates the fair value hierarchy based on the levels of inputs we utilized to determine such fair value:
Due to the insignificant activity within the Level 3 assets during the three months ended March 31, 2024 and 2023, we have omitted the additional disclosures relating to the changes in Level 3 assets measured at fair value on a recurring basis and the quantitative information about Level 3 unobservable inputs. FAIR VALUE MEASUREMENTS — NON-RECURRING BASIS We measure the fair value of certain assets on a non-recurring basis when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Net impairment charges recorded on assets measured at fair value on a non-recurring basis were immaterial during the three months ended March 31, 2024 and 2023. FAIR VALUE MEASUREMENTS — VALUATION METHODOLOGIES AND ASSUMPTIONS See Note 18 of the Notes to the Consolidated Financial Statements in Part II - Item 8 included in our Annual Report for information regarding our methods and assumptions used to estimate fair value.
|
Subsequent Events |
3 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||
Subsequent Events [Abstract] | |||||||
Subsequent Events |
On April 1, 2024, we completed our previously announced acquisition of all of the outstanding common stock of Foursight Capital LLC (“Foursight”), a wholly owned subsidiary of Jefferies Financial Group, Inc. Foursight is an automobile finance company that purchases and services automobile retail installment contracts. Contracts are sourced through an extensive network of auto dealers. As of March 31, 2024, Foursight had approximately $900 million of auto loan receivables. We are currently in the process of completing the purchase accounting, which will be disclosed in subsequent filings.
|
Pay vs Performance Disclosure - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Pay vs Performance Disclosure | ||
Net income | $ 155 | $ 179 |
Insider Trading Arrangements |
3 Months Ended |
---|---|
Mar. 31, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Business and Basis of Presentation (Policies) |
3 Months Ended |
---|---|
Mar. 31, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
BASIS OF PRESENTATION | We prepared our condensed consolidated financial statements using generally accepted accounting principles in the United States of America (“GAAP”). These statements are unaudited. The year-end condensed balance sheet data was derived from our audited financial statements but does not include all disclosures required by GAAP. |
CONSOLIDATION | The statements include the accounts of OMH, its wholly owned subsidiaries, and variable interest entities (“VIEs”) in which we hold a controlling financial interest and for which we are considered to be the primary beneficiary as of the financial statement date.We eliminated all material intercompany accounts and transactions. |
USE OF ESTIMATES | We made judgments, estimates, and assumptions that affect amounts reported in our condensed consolidated financial statements and disclosures of contingent assets and liabilities. In management’s opinion, the condensed consolidated financial statements include the normal, recurring adjustments necessary for a fair statement of results. Actual results could differ from our estimates. We evaluated the effects of and the need to disclose events that occurred subsequent to the balance sheet date. |
ACCOUNTING PRONUNCEMENTS TO BE ADOPTED | ACCOUNTING PRONOUNCEMENTS TO BE ADOPTED Segment Reporting In November of 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires annual and interim disclosure of significant segment expenses and other segment items. The amendments in this ASU will become effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied on a retrospective basis to all prior periods presented in the financial statements. We are currently evaluating the impact of the standard on our segment disclosures. Income Taxes In December of 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disaggregated information in the rate reconciliation and income taxes paid disclosures. The amendments in this ASU will become effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied on a prospective basis, with retrospective application allowed. We are currently evaluating the impact of the standard on our income tax disclosures. We do not believe that any accounting pronouncements issued, but not yet effective, would have a material impact on our consolidated financial statements or disclosures, if adopted.
|
Finance Receivables (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of components of net finance receivables by type | Components of our net finance receivables were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of net finance receivables by type and by days delinquent | The following tables below are a summary of our personal loans by the year of origination and number of days delinquent:
* Represents gross charge-offs for the three months ended March 31, 2024.
* Represents gross charge-offs for the three months ended March 31, 2023. The following tables below are a summary of our auto finance loans by the year of origination and number of days delinquent:
* Represents gross charge-offs for the three months ended March 31, 2024.
* Represents gross charge-offs for the three months ended March 31, 2023. The following is a summary of credit cards by number of days delinquent:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of information regarding Modified Finance Receivables | The period-end carrying value of finance receivables modified during the period were as follows:
The financial effect of modifications made during the period were as follows:
The performance of finance receivables modified within the previous 12 months by delinquency status was as follows:
* Excludes $55 million of personal loan receivables and $1 million of auto finance receivables that were modified and subsequently charged off within the previous 12 months. The period-end carrying value of finance receivables that defaulted during the period to cause the receivable to be considered nonperforming (90 days or more contractually past due) and had been modified within the 12 months preceding the default were as follows:
* There were no modified finance receivables for which there was a default during the three months ended March 31, 2023 to cause the modified finance receivable to be considered nonperforming (90 days or more past due).
|
Allowance for Finance Receivable Losses (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in the allowance for finance receivable losses by finance receivable type | Changes in the allowance for finance receivable losses were as follows:
* As a result of the adoption of ASU 2022-02, we recorded a one-time adjustment to the allowance for finance receivable losses. See Notes 3, 4, and 5 of the Notes to the Consolidated Financial Statements in Part II - Item 8 of our Annual Report for additional information on the adoption of ASU 2022-02.
|
Investment Securities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of the cost/amortized cost, unrealized gains and losses, and fair value of available-for-sale securities by type | Cost/amortized cost, allowance for credit losses, unrealized gains and losses, and fair value of fixed maturity available-for-sale securities by type were as follows:
* The allowance for credit losses related to our investment securities as of March 31, 2024 and 2023 was immaterial.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of fair value and unrealized losses on investment securities by type and length of time in a continuous unrealized loss position | Fair value and unrealized losses on available-for-sale securities by type and length of time in a continuous unrealized loss position without an allowance for credit losses were as follows:
* Unrealized losses on certain available-for-sale securities were less than $1 million and, therefore, were not quantified in the table above.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of contractual maturities of fixed-maturity available-for-sale securities | Contractual maturities of fixed-maturity available-for-sale securities at March 31, 2024 were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of fair value of other securities by type | The fair value of other securities by type was as follows:
|
Long-term Debt (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of principal maturities of long-term debt | Principal maturities of long-term debt by type of debt at March 31, 2024 were as follows:
(a) Pursuant to the Base Indenture, the Supplemental Indentures, and the Guaranty Agreements, OMH agreed to fully and unconditionally guarantee, on a senior unsecured basis, payments of principal, premium and interest on the Unsecured Notes and Junior Subordinated Debenture. The OMH guarantees of OMFC’s long-term debt are subject to customary release provisions. (b) The interest rates shown are the range of contractual rates in effect at March 31, 2024. (c) Securitizations, private secured term funding, and borrowings under the revolving conduit facilities are not included in the above maturities by period due to their variable monthly repayments, which may result in pay-off prior to the stated maturity date. See Note 7 for further information on our long-term debt associated with securitizations, private secured term funding, and revolving conduit facilities. (d) Debt issuance costs are reported as a direct deduction from long-term debt, with the exception of debt issuance costs associated with our revolving conduit facilities, credit card revolving variable funding note (“VFN”) facilities, and unsecured corporate revolver, which totaled $38 million at March 31, 2024 and are reported in Other assets in our condensed consolidated balance sheets.
|
Variable Interest Entities (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carrying amounts of consolidated VIE assets and liabilities | The carrying amounts of consolidated VIE assets and liabilities associated with our securitization trusts, private secured term funding, revolving conduit facilities, and credit card revolving VFN facilities were as follows:
|
Insurance (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Changes in the reserve for unpaid claims and loss adjustment expenses | Changes in the reserve for unpaid claims and loss adjustment expenses (net of reinsurance recoverables) on our short-duration insurance contracts:
* At March 31, 2024, there was a redundancy in the prior years’ net reserves due to favorable development of collateral protection claims during the period. At March 31, 2023, there was a redundancy in the prior years’ net reserves, due to favorable development of credit disability claims during the period.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Future Policy Benefit, Activity | The present value of expected net premiums on long-duration insurance contracts were as follows:
The present value of expected future policy benefits on long-duration insurance contracts were as follows:
The net liability for future policy benefits on long-duration insurance contracts were as follows:
The following table reconciles the net liability for future policy benefits to Insurance claims and policyholder liabilities in the condensed consolidated balance sheets:
* Other primarily includes reserves for short-duration contracts that are payable to third-party beneficiaries. The undiscounted and discounted expected future gross premiums and expected future benefits and expenses for our long-duration insurance contracts were as follows:
The revenue and interest accretion related to our long-duration insurance contracts recognized in the condensed consolidated statements of operations were as follows:
The weighted-average interest rates for the liability of future policy benefits for our long-duration insurance contracts were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques | The expected and actual experience for mortality, morbidity, and lapses of the liability for future policy benefits were as follows:
|
Capital Stock and Earnings Per Share (OMH Only) (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in shares issued and outstanding | Changes in OMH shares of common stock issued and outstanding were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Computation of earnings per share | The computation of earnings per share was as follows:
|
Accumulated Other Comprehensive Income (Loss) (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Changes, net of tax, in accumulated other comprehensive income (loss) | Changes, net of tax, in Accumulated other comprehensive income (loss) were as follows:
(a) There were no material amounts related to available-for-sale debt securities for which an allowance for credit losses was recorded during the three months ended March 31, 2024 and 2023. (b) Other primarily includes changes in the fair value of our mark-to-market derivative instruments that have been designated as cash flow hedges. Reclassification adjustments from Accumulated other comprehensive income (loss) to the applicable line item on our condensed consolidated statements of operations were immaterial for the three months ended March 31, 2024 and 2023.
|
Segment Information (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Information about the Company's segments | The following tables present information about C&I and Other, as well as reconciliations to the condensed consolidated financial statement amounts.
|
Fair Value Measurements (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of fair values and carrying values of financial instruments and fair value hierarchy based on the level of inputs utilized to determine such fair value | The following table presents the carrying amounts and estimated fair values of our financial instruments and indicates the level in the fair value hierarchy of the estimated fair value measurement based on the observability of the inputs used:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of assets and liabilities measured at fair value on a recurring basis | The following tables present information about our assets measured at fair value on a recurring basis and indicates the fair value hierarchy based on the levels of inputs we utilized to determine such fair value:
|
Finance Receivables - Additional Information (Details) - USD ($) |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Dec. 31, 2023 |
|
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Whole loan sale flow agreement, loans sold | $ 630,000,000 | ||
Proceeds from sale of gross finance receivables | 110,000,000 | $ 180,000,000 | |
Gain on sale of financing receivables | 6,000,000 | 17,000,000 | |
Unused credit card lines | $ 263,000,000 | $ 223,000,000 | |
Credit Cards | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Threshold period past due | 180 days | ||
Minimum | Auto Finance | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Finance receivables, original term | 3 years | ||
Minimum | Personal Loans | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Finance receivables, original term | 3 years | ||
Maximum | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Whole loan sale flow agreement, commitment period | 2 years | ||
Maximum | Auto Finance | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Finance receivables, original term | 6 years | ||
Maximum | Personal Loans | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Finance receivables, original term | 6 years | ||
Unlikely to be Collected Financing Receivable | Total Consumer Loans | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Threshold period past due | 60 days | ||
Nonperforming (Nonaccrual) | Total Consumer Loans | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Threshold period past due | 90 days | ||
Interest income | $ 0 | 0 | |
Nonperforming (Nonaccrual) | Auto Finance | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Reversal of net accrued finance charges and fees | 0 | 0 | |
Interest income | 0 | 0 | |
Nonperforming (Nonaccrual) | Personal Loans | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Reversal of net accrued finance charges and fees | $ 41,000,000 | 37,000,000 | |
Nonperforming (Nonaccrual) | Credit Cards | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Reversal of net accrued finance charges and fees | $ 0 |
Finance Receivables - Net Finance Receivables by Type (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
---|---|---|
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Gross finance receivables | $ 20,795 | $ 21,043 |
Unearned fees | (233) | (236) |
Accrued finance charges and fees | 318 | 333 |
Deferred origination costs | 203 | 209 |
Financing Receivable, Total | 21,083 | 21,349 |
Total Consumer Loans | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Gross finance receivables | 20,418 | 20,721 |
Unearned fees | (233) | (236) |
Accrued finance charges and fees | 318 | 333 |
Deferred origination costs | 194 | 201 |
Financing Receivable, Total | 20,697 | 21,019 |
Personal Loans | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Gross finance receivables | 19,575 | 19,977 |
Unearned fees | (217) | (223) |
Accrued finance charges and fees | 310 | 326 |
Deferred origination costs | 186 | 194 |
Financing Receivable, Total | 19,854 | 20,274 |
Auto Finance | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Gross finance receivables | 843 | 744 |
Unearned fees | (16) | (13) |
Accrued finance charges and fees | 8 | 7 |
Deferred origination costs | 8 | 7 |
Financing Receivable, Total | 843 | 745 |
Credit Cards | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Gross finance receivables | 377 | 322 |
Unearned fees | 0 | 0 |
Accrued finance charges and fees | 0 | 0 |
Deferred origination costs | 9 | 8 |
Financing Receivable, Total | $ 386 | $ 330 |
Finance Receivables - Delinquent and Nonperforming Finance Receivables, by Year of Origination (Details) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Dec. 31, 2023 |
|
Financing Receivable By Year Originated | |||
Financing Receivable, Total | $ 21,083 | $ 21,349 | |
Gross charge-offs * | |||
Financing Receivable, Gross Charge-Offs | 534 | $ 451 | |
Personal Loans | |||
Financing Receivable By Year Originated | |||
Year One | 2,214 | 10,071 | |
Prior Year Two | 8,996 | 6,043 | |
Prior Year Three | 5,230 | 2,744 | |
Prior Year Four | 2,309 | 860 | |
Prior Year Five | 687 | 423 | |
Prior Year Six | 418 | 133 | |
Financing Receivable, Total | 19,854 | 20,274 | |
Gross charge-offs * | |||
Year One | 0 | 0 | |
Prior Year Two | 115 | 136 | |
Prior Year Three | 223 | 198 | |
Prior Year Four | 119 | 59 | |
Prior Year Five | 33 | 34 | |
Prior Year Six | 23 | 14 | |
Financing Receivable, Gross Charge-Offs | 513 | $ 441 | |
Auto Finance | |||
Financing Receivable By Year Originated | |||
Year One | 163 | 489 | |
Prior Year Two | 453 | 217 | |
Prior Year Three | 193 | 37 | |
Prior Year Four | 33 | 2 | |
Prior Year Five | 1 | 0 | |
Prior Year Six | 0 | 0 | |
Financing Receivable, Total | 843 | 745 | |
Gross charge-offs * | |||
Year One | 0 | 0 | |
Prior Year Two | 3 | 3 | |
Prior Year Three | 5 | 1 | |
Prior Year Four | 1 | 0 | |
Prior Year Five | 0 | 0 | |
Prior Year Six | 0 | 0 | |
Financing Receivable, Gross Charge-Offs | 9 | 4 | |
Performing | Personal Loans | |||
Financing Receivable By Year Originated | |||
Year One | 2,214 | 9,946 | |
Prior Year Two | 8,813 | 5,784 | |
Prior Year Three | 5,009 | 2,601 | |
Prior Year Four | 2,191 | 820 | |
Prior Year Five | 653 | 402 | |
Prior Year Six | 393 | 125 | |
Financing Receivable, Total | 19,273 | 19,678 | |
Performing | Auto Finance | |||
Financing Receivable By Year Originated | |||
Year One | 163 | 486 | |
Prior Year Two | 449 | 212 | |
Prior Year Three | 188 | 36 | |
Prior Year Four | 32 | 2 | |
Prior Year Five | 1 | 0 | |
Prior Year Six | 0 | 0 | |
Financing Receivable, Total | 833 | 736 | |
Performing | Current | Personal Loans | |||
Financing Receivable By Year Originated | |||
Year One | 2,212 | 9,759 | |
Prior Year Two | 8,615 | 5,527 | |
Prior Year Three | 4,822 | 2,454 | |
Prior Year Four | 2,089 | 776 | |
Prior Year Five | 622 | 376 | |
Prior Year Six | 368 | 114 | |
Financing Receivable, Total | 18,728 | 19,006 | |
Performing | Current | Auto Finance | |||
Financing Receivable By Year Originated | |||
Year One | 163 | 480 | |
Prior Year Two | 441 | 203 | |
Prior Year Three | 181 | 34 | |
Prior Year Four | 30 | 2 | |
Prior Year Five | 1 | 0 | |
Prior Year Six | 0 | 0 | |
Financing Receivable, Total | 816 | 719 | |
Performing | 30-59 days past due | Personal Loans | |||
Financing Receivable By Year Originated | |||
Year One | 2 | 113 | |
Prior Year Two | 118 | 153 | |
Prior Year Three | 111 | 88 | |
Prior Year Four | 61 | 27 | |
Prior Year Five | 19 | 16 | |
Prior Year Six | 15 | 7 | |
Financing Receivable, Total | 326 | 404 | |
Performing | 30-59 days past due | Auto Finance | |||
Financing Receivable By Year Originated | |||
Year One | 0 | 4 | |
Prior Year Two | 5 | 6 | |
Prior Year Three | 5 | 2 | |
Prior Year Four | 1 | 0 | |
Prior Year Five | 0 | 0 | |
Prior Year Six | 0 | 0 | |
Financing Receivable, Total | 11 | 12 | |
Performing | 60-89 days past due | Personal Loans | |||
Financing Receivable By Year Originated | |||
Year One | 0 | 74 | |
Prior Year Two | 80 | 104 | |
Prior Year Three | 76 | 59 | |
Prior Year Four | 41 | 17 | |
Prior Year Five | 12 | 10 | |
Prior Year Six | 10 | 4 | |
Financing Receivable, Total | 219 | 268 | |
Performing | 60-89 days past due | Auto Finance | |||
Financing Receivable By Year Originated | |||
Year One | 0 | 2 | |
Prior Year Two | 3 | 3 | |
Prior Year Three | 2 | 0 | |
Prior Year Four | 1 | 0 | |
Prior Year Five | 0 | 0 | |
Prior Year Six | 0 | 0 | |
Financing Receivable, Total | 6 | 5 | |
Nonperforming (Nonaccrual) | 90+ days past due | Personal Loans | |||
Financing Receivable By Year Originated | |||
Year One | 0 | 125 | |
Prior Year Two | 183 | 259 | |
Prior Year Three | 221 | 143 | |
Prior Year Four | 118 | 40 | |
Prior Year Five | 34 | 21 | |
Prior Year Six | 25 | 8 | |
Financing Receivable, Total | 581 | 596 | |
Nonperforming (Nonaccrual) | 90+ days past due | Auto Finance | |||
Financing Receivable By Year Originated | |||
Year One | 0 | 3 | |
Prior Year Two | 4 | 5 | |
Prior Year Three | 5 | 1 | |
Prior Year Four | 1 | 0 | |
Prior Year Five | 0 | 0 | |
Prior Year Six | 0 | 0 | |
Financing Receivable, Total | $ 10 | $ 9 |
Finance Receivables - Summary of Credit Cards by Number of Days Delinquent (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
---|---|---|
Delinquency by finance receivables type | ||
Net finance receivables | $ 21,083 | $ 21,349 |
Credit Cards | ||
Delinquency by finance receivables type | ||
Net finance receivables | 386 | 330 |
Credit Cards | Current | ||
Delinquency by finance receivables type | ||
Net finance receivables | 343 | 297 |
Credit Cards | 30-59 days past due | ||
Delinquency by finance receivables type | ||
Net finance receivables | 10 | 9 |
Credit Cards | 60-89 days past due | ||
Delinquency by finance receivables type | ||
Net finance receivables | 9 | 7 |
Credit Cards | 90+ days past due | ||
Delinquency by finance receivables type | ||
Net finance receivables | $ 24 | $ 17 |
Finance Receivables - Modified Financing Receivables To Borrowers Experiencing Financial Difficulty (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Personal Loans | ||
Financing Receivable, Modified [Line Items] | ||
Modifications to borrowers experiencing financial difficulties | $ 275 | $ 221 |
Modifications as a percent of net finance receivables by class | 1.38% | 1.15% |
Personal Loans | Interest rate reduction and term extension | ||
Financing Receivable, Modified [Line Items] | ||
Modifications to borrowers experiencing financial difficulties | $ 156 | $ 125 |
Personal Loans | Interest rate reduction and principal forgiveness | ||
Financing Receivable, Modified [Line Items] | ||
Modifications to borrowers experiencing financial difficulties | 119 | 96 |
Auto Finance | ||
Financing Receivable, Modified [Line Items] | ||
Modifications to borrowers experiencing financial difficulties | $ 5 | $ 1 |
Modifications as a percent of net finance receivables by class | 0.56% | 0.33% |
Auto Finance | Interest rate reduction and term extension | ||
Financing Receivable, Modified [Line Items] | ||
Modifications to borrowers experiencing financial difficulties | $ 5 | $ 1 |
Auto Finance | Interest rate reduction and principal forgiveness | ||
Financing Receivable, Modified [Line Items] | ||
Modifications to borrowers experiencing financial difficulties | $ 0 | $ 0 |
Finance Receivables - Modified Financing Receivables Financial Effects (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Personal Loans | ||
Financing Receivable, Modified [Line Items] | ||
Weighted-average interest rate reduction | 17.56% | 21.38% |
Weighted-average term extension (months) | 25 months | 19 months |
Principal/interest forgiveness | $ 11 | $ 11 |
Auto Finance | ||
Financing Receivable, Modified [Line Items] | ||
Weighted-average interest rate reduction | 11.16% | 12.56% |
Weighted-average term extension (months) | 28 months | 20 months |
Principal/interest forgiveness | $ 0 | $ 0 |
Finance Receivables - Modified Financing Receivables Days Delinquent (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Personal Loans | ||
Financing Receivable, Modified [Line Items] | ||
Modified financing receivables | $ 815 | $ 221 |
Finance receivables subsequently charged off | 55 | |
Auto Finance | ||
Financing Receivable, Modified [Line Items] | ||
Modified financing receivables | 9 | 1 |
Finance receivables subsequently charged off | 1 | |
Current | Personal Loans | ||
Financing Receivable, Modified [Line Items] | ||
Modified financing receivables | 611 | 158 |
Current | Auto Finance | ||
Financing Receivable, Modified [Line Items] | ||
Modified financing receivables | 7 | 1 |
30-59 days past due | Personal Loans | ||
Financing Receivable, Modified [Line Items] | ||
Modified financing receivables | 55 | 27 |
30-59 days past due | Auto Finance | ||
Financing Receivable, Modified [Line Items] | ||
Modified financing receivables | 1 | 0 |
60-89 days past due | Personal Loans | ||
Financing Receivable, Modified [Line Items] | ||
Modified financing receivables | 44 | 14 |
60-89 days past due | Auto Finance | ||
Financing Receivable, Modified [Line Items] | ||
Modified financing receivables | 0 | 0 |
90+ days past due | Personal Loans | ||
Financing Receivable, Modified [Line Items] | ||
Modified financing receivables | 105 | 22 |
90+ days past due | Auto Finance | ||
Financing Receivable, Modified [Line Items] | ||
Modified financing receivables | $ 1 | $ 0 |
Finance Receivables - Modified Finance Receivables, Nonperforming (Details) - Nonperforming (Nonaccrual) $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2024
USD ($)
| |
Personal Loans | |
Financing Receivable, Modified [Line Items] | |
Modified finance receivables | $ 60 |
Personal Loans | Interest rate reduction and term extension | |
Financing Receivable, Modified [Line Items] | |
Modified finance receivables | 44 |
Personal Loans | Interest rate reduction and principal forgiveness | |
Financing Receivable, Modified [Line Items] | |
Modified finance receivables | 16 |
Auto Finance | |
Financing Receivable, Modified [Line Items] | |
Modified finance receivables | 1 |
Auto Finance | Interest rate reduction and term extension | |
Financing Receivable, Modified [Line Items] | |
Modified finance receivables | 1 |
Auto Finance | Interest rate reduction and principal forgiveness | |
Financing Receivable, Modified [Line Items] | |
Modified finance receivables | $ 0 |
Allowance for Finance Receivable Losses - Changes in Allowance by Type (Details) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Dec. 31, 2023 |
|
Changes in allowance for finance receivable losses | |||
Balance at beginning of period | $ 2,480 | $ 2,311 | $ 2,311 |
Provision for finance receivable losses | 431 | 385 | |
Charge-offs | (534) | (451) | |
Recoveries | 77 | 69 | |
Balance at end of period | 2,454 | 2,298 | 2,480 |
Net impact of adoption of ASU 2022-02 | |||
Changes in allowance for finance receivable losses | |||
Balance at beginning of period | (16) | (16) | |
Total Consumer Loans | |||
Changes in allowance for finance receivable losses | |||
Balance at beginning of period | 2,415 | 2,290 | 2,290 |
Provision for finance receivable losses | 406 | 377 | |
Charge-offs | (522) | (445) | |
Recoveries | 77 | 69 | |
Balance at end of period | 2,376 | 2,275 | 2,415 |
Total Consumer Loans | Net impact of adoption of ASU 2022-02 | |||
Changes in allowance for finance receivable losses | |||
Balance at beginning of period | (16) | (16) | |
Credit Cards | |||
Changes in allowance for finance receivable losses | |||
Balance at beginning of period | 65 | 21 | 21 |
Provision for finance receivable losses | 25 | 8 | |
Charge-offs | (12) | (6) | |
Recoveries | 0 | 0 | |
Balance at end of period | $ 78 | 23 | 65 |
Credit Cards | Net impact of adoption of ASU 2022-02 | |||
Changes in allowance for finance receivable losses | |||
Balance at beginning of period | $ 0 | $ 0 |
Investment Securities - Cost/Amortized, Unrealized Gains/Losses & FV on AFS Investment Securities (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
---|---|---|
Debt Securities, Available-for-sale [Line Items] | ||
Cost/ Amortized Cost | $ 1,743 | $ 1,765 |
Unrealized Gains | 4 | 5 |
Unrealized Losses | (129) | (123) |
Fair Value | 1,618 | 1,647 |
U.S. government and government sponsored entities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost/ Amortized Cost | 19 | 18 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | (1) | (1) |
Fair Value | 18 | 17 |
Obligations of states, municipalities, and political subdivisions | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost/ Amortized Cost | 72 | 72 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | (6) | (6) |
Fair Value | 66 | 66 |
Commercial paper | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost/ Amortized Cost | 21 | 14 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | 0 | 0 |
Fair Value | 21 | 14 |
Non-U.S. government and government sponsored entities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost/ Amortized Cost | 161 | 172 |
Unrealized Gains | 0 | 1 |
Unrealized Losses | (7) | (6) |
Fair Value | 154 | 167 |
Corporate debt | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost/ Amortized Cost | 1,149 | 1,160 |
Unrealized Gains | 4 | 4 |
Unrealized Losses | (83) | (79) |
Fair Value | 1,070 | 1,085 |
RMBS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost/ Amortized Cost | 204 | 202 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | (24) | (22) |
Fair Value | 180 | 180 |
CMBS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost/ Amortized Cost | 36 | 36 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | (3) | (3) |
Fair Value | 33 | 33 |
CDO/ABS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost/ Amortized Cost | 81 | 91 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | (5) | (6) |
Fair Value | $ 76 | $ 85 |
Investment Securities - Additional Information (Details) |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2024
USD ($)
investment
|
Mar. 31, 2023
USD ($)
|
Mar. 31, 2022
USD ($)
|
Dec. 31, 2023
USD ($)
investment
|
|
Investments, Debt and Equity Securities [Abstract] | ||||
Interest receivable | $ 14,000,000 | $ 14,000,000 | ||
Investment securities in an unrealized loss position | investment | 2,036 | 1,984 | ||
Proceeds from sales and redemptions | $ 19,000,000 | $ 26,000,000 | ||
Securities on deposit with third parties | 512,000,000 | $ 524,000,000 | ||
Net unrealized gains (losses) on other securities held | $ 0 | $ 0 |
Investment Securities - Fair Value and Unrealized Losses on AFS Investment Securities (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
---|---|---|
Fair Value | ||
Less Than 12 Months | $ 122 | $ 62 |
12 Months or Longer | 1,292 | 1,341 |
Total | 1,414 | 1,403 |
Unrealized Losses * | ||
Less Than 12 Months | 0 | 0 |
12 Months or Longer | (129) | (123) |
Total | (129) | (123) |
U.S. government and government sponsored entities | ||
Fair Value | ||
Less Than 12 Months | 4 | 1 |
12 Months or Longer | 11 | 11 |
Total | 15 | 12 |
Unrealized Losses * | ||
Less Than 12 Months | 0 | 0 |
12 Months or Longer | (1) | (1) |
Total | (1) | (1) |
Obligations of states, municipalities, and political subdivisions | ||
Fair Value | ||
Less Than 12 Months | 2 | 2 |
12 Months or Longer | 61 | 62 |
Total | 63 | 64 |
Unrealized Losses * | ||
Less Than 12 Months | 0 | 0 |
12 Months or Longer | (6) | (6) |
Total | (6) | (6) |
Commercial paper | ||
Fair Value | ||
Less Than 12 Months | 21 | 14 |
12 Months or Longer | 0 | 0 |
Total | 21 | 14 |
Unrealized Losses * | ||
Less Than 12 Months | 0 | 0 |
12 Months or Longer | 0 | 0 |
Total | 0 | 0 |
Non-U.S. government and government sponsored entities | ||
Fair Value | ||
Less Than 12 Months | 26 | 22 |
12 Months or Longer | 96 | 97 |
Total | 122 | 119 |
Unrealized Losses * | ||
Less Than 12 Months | 0 | 0 |
12 Months or Longer | (7) | (6) |
Total | (7) | (6) |
Corporate debt | ||
Fair Value | ||
Less Than 12 Months | 60 | 15 |
12 Months or Longer | 885 | 925 |
Total | 945 | 940 |
Unrealized Losses * | ||
Less Than 12 Months | 0 | 0 |
12 Months or Longer | (83) | (79) |
Total | (83) | (79) |
RMBS | ||
Fair Value | ||
Less Than 12 Months | 5 | 5 |
12 Months or Longer | 152 | 152 |
Total | 157 | 157 |
Unrealized Losses * | ||
Less Than 12 Months | 0 | 0 |
12 Months or Longer | (24) | (22) |
Total | (24) | (22) |
CMBS | ||
Fair Value | ||
Less Than 12 Months | 0 | 2 |
12 Months or Longer | 33 | 32 |
Total | 33 | 34 |
Unrealized Losses * | ||
Less Than 12 Months | 0 | 0 |
12 Months or Longer | (3) | (3) |
Total | (3) | (3) |
CDO/ABS | ||
Fair Value | ||
Less Than 12 Months | 4 | 1 |
12 Months or Longer | 54 | 62 |
Total | 58 | 63 |
Unrealized Losses * | ||
Less Than 12 Months | 0 | 0 |
12 Months or Longer | (5) | (6) |
Total | $ (5) | $ (6) |
Investment Securities - Contractual Maturities of AFS Investment Securities (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
---|---|---|
Fixed maturities, excluding mortgage-backed, asset-backed, and collateralized securities: | ||
Due in 1 year or less | $ 156 | |
Due after 1 year through 5 years | 575 | |
Due after 5 years through 10 years | 476 | |
Due after 10 years | 122 | |
Mortgage-backed, asset-backed, and collateralized securities | 289 | |
Fair Value | 1,618 | $ 1,647 |
Fixed maturities, excluding mortgage-backed, asset-backed, and collateralized securities: | ||
Due in 1 year or less | 157 | |
Due after 1 year through 5 years | 598 | |
Due after 5 years through 10 years | 529 | |
Due after 10 years | 138 | |
Mortgage-backed, asset-backed, and collateralized securities | 321 | |
Cost/ Amortized Cost | $ 1,743 | $ 1,765 |
Investment Securities - Fair Value of Other Securities (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
---|---|---|
Debt and Equity Securities, FV-NI [Line Items] | ||
Bonds | $ 22 | $ 22 |
Total | 73 | 72 |
Preferred stock | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Equity securities | 15 | 16 |
Common stock | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Equity securities | $ 36 | $ 34 |
Long-term Debt - Principal Maturities of Long-Term Debt (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
---|---|---|
Principal maturities of long-term debt by type of debt | ||
Remainder of 2024 | $ 0 | |
2025 | 1,110 | |
2026 | 1,600 | |
2027 | 750 | |
2028 | 1,350 | |
2029-2067 | 3,532 | |
Secured | 11,463 | |
Total principal maturities | 19,805 | |
Long-term debt | 19,520 | $ 19,813 |
Debt issuance costs | (99) | |
Securitizations | ||
Principal maturities of long-term debt by type of debt | ||
Remainder of 2024 | 0 | |
2025 | 0 | |
2026 | 0 | |
2027 | 0 | |
2028 | 0 | |
2029-2067 | 0 | |
Secured | 11,112 | |
Total principal maturities | 11,112 | |
Long-term debt | 11,069 | |
Debt issuance costs | $ (39) | |
Securitizations | Minimum | ||
Long-term debt | ||
Interest rate | 0.87% | |
Securitizations | Maximum | ||
Long-term debt | ||
Interest rate | 7.52% | |
Private Secured Term Funding | ||
Principal maturities of long-term debt by type of debt | ||
Remainder of 2024 | $ 0 | |
2025 | 0 | |
2026 | 0 | |
2027 | 0 | |
2028 | 0 | |
2029-2067 | 0 | |
Secured | 350 | |
Total principal maturities | 350 | |
Long-term debt | 350 | |
Debt issuance costs | $ 0 | |
Private Secured Term Funding | Minimum | ||
Long-term debt | ||
Interest rate | 6.35% | |
Revolving Conduit Facilities | ||
Principal maturities of long-term debt by type of debt | ||
Remainder of 2024 | $ 0 | |
2025 | 0 | |
2026 | 0 | |
2027 | 0 | |
2028 | 0 | |
2029-2067 | 0 | |
Secured | 1 | |
Total principal maturities | 1 | |
Long-term debt | 1 | |
Debt issuance costs | $ 0 | |
Revolving Conduit Facilities | Minimum | ||
Long-term debt | ||
Interest rate | 6.81% | |
Revolving Conduit Facilities And Unsecured Corporate Revolver | ||
Principal maturities of long-term debt by type of debt | ||
Debt issuance costs | $ 38 | |
Unsecured Notes | Unsecured Notes | ||
Principal maturities of long-term debt by type of debt | ||
Remainder of 2024 | 0 | |
2025 | 1,110 | |
2026 | 1,600 | |
2027 | 750 | |
2028 | 1,350 | |
2029-2067 | 3,182 | |
Total principal maturities | 7,992 | |
Long-term debt | 7,928 | |
Debt issuance costs | $ (60) | |
Unsecured Notes | Unsecured Notes | Minimum | ||
Long-term debt | ||
Interest rate | 3.50% | |
Unsecured Notes | Unsecured Notes | Maximum | ||
Long-term debt | ||
Interest rate | 9.00% | |
Junior Subordinated Debt | ||
Long-term debt | ||
Interest rate | 7.33% | |
Principal maturities of long-term debt by type of debt | ||
Remainder of 2024 | $ 0 | |
2025 | 0 | |
2026 | 0 | |
2027 | 0 | |
2028 | 0 | |
2029-2067 | 350 | |
Total principal maturities | 350 | |
Long-term debt | 172 | |
Debt issuance costs | $ 0 |
Long-term Debt- Narrative (Details) - Revolver - OMFC - USD ($) |
Oct. 25, 2021 |
Mar. 31, 2024 |
---|---|---|
Debt Instrument [Line Items] | ||
Total borrowing capacity | $ 1,300,000,000 | |
Debt instrument, term | 5 years | |
Outstanding balance | $ 0 |
Variable Interest Entities - Carrying Amount of Consolidated VIEs (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
Mar. 31, 2023 |
Dec. 31, 2022 |
||||
---|---|---|---|---|---|---|---|---|
Variable Interest Entity [Line Items] | ||||||||
Cash and cash equivalents | $ 831 | $ 1,014 | $ 544 | |||||
Net finance receivables | 21,083 | 21,349 | ||||||
Allowance for finance receivable losses | 2,454 | 2,480 | 2,298 | $ 2,311 | ||||
Restricted cash and restricted cash equivalents | 599 | [1] | 534 | $ 531 | [1] | |||
Other assets | 1,211 | 1,232 | ||||||
Long-term debt | 19,520 | 19,813 | ||||||
Consolidated VIEs | ||||||||
Variable Interest Entity [Line Items] | ||||||||
Cash and cash equivalents | 3 | 2 | ||||||
Net finance receivables | 12,641 | 12,780 | ||||||
Allowance for finance receivable losses | 1,429 | 1,428 | ||||||
Restricted cash and restricted cash equivalents | 576 | 523 | ||||||
Other assets | 36 | 32 | ||||||
Long-term debt | 11,420 | 11,579 | ||||||
Other liabilities | $ 27 | $ 27 | ||||||
|
Variable Interest Entities - Consolidated VIEs (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Variable Interest Entity [Line Items] | ||
Interest expense | $ 277 | $ 239 |
Consolidated VIEs | ||
Variable Interest Entity [Line Items] | ||
Interest expense | $ 138 | $ 101 |
Variable Interest Entities - Securitized Borrowings (Details) - Securitizations |
3 Months Ended |
---|---|
Mar. 31, 2024 | |
Minimum | |
Debt Instrument [Line Items] | |
Debt instrument, term | 2 years |
Maximum | |
Debt Instrument [Line Items] | |
Debt instrument, term | 7 years |
Variable Interest Entities - Credit Card Revolving VFN Facilities (Details) - Consolidated VIEs $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2024
USD ($)
vfn_facility
| |
Debt Instrument [Line Items] | |
Number of revolving credit card VFN facilities | vfn_facility | 2 |
Revolving Credit Card VFN Facility | |
Debt Instrument [Line Items] | |
Total borrowing capacity | $ | $ 300 |
Debt instrument, term | 6 years |
Variable Interest Entities - Private Secured Term Funding (Details) - Private Secured Term Funding - Consolidated VIEs |
3 Months Ended |
---|---|
Mar. 31, 2024
USD ($)
| |
Debt Instrument [Line Items] | |
Debt instrument, principal amount | $ 350,000,000 |
Payments required in first 3 years | $ 0 |
Amortization period after first 3 years | 1 year |
Variable Interest Entities - Revolving Conduit Facilities (Details) - Consolidated VIEs - Revolving Conduit Facilities $ in Billions |
3 Months Ended |
---|---|
Mar. 31, 2024
USD ($)
facility
| |
Line of Credit Facility [Line Items] | |
Number of conduit facilities | facility | 16 |
Total borrowing capacity | $ | $ 6.4 |
Debt instrument, term | 9 years |
Insurance - Changes in the Reserve for Unpaid Claims and Loss Adjustment Expenses (Details) - USD ($) $ in Millions |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
Liability for unpaid claims and claims adjustment expense | ||||
Balance at beginning of period | $ 108 | $ 93 | ||
Less reinsurance recoverables | (3) | (3) | $ (3) | $ (3) |
Net balance at beginning of period | 105 | 90 | ||
Additions for losses and loss adjustment expenses incurred to: | ||||
Current year | 52 | 42 | ||
Prior years | (5) | (1) | ||
Total | 47 | 41 | ||
Reductions for losses and loss adjustment expenses paid related to: | ||||
Current year | (15) | (12) | ||
Prior years | (32) | (27) | ||
Total | (47) | (39) | ||
Net balance at end of period | 105 | 92 | ||
Plus reinsurance recoverables | 3 | 3 | $ 3 | $ 3 |
Balance at end of period | $ 108 | $ 95 |
Insurance - Present Value of Expected Net Premium And Future Policy Benefits (Details) - USD ($) $ in Millions |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
Term and Whole Life | ||||
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||
Balance at beginning of period | $ 217 | $ 252 | ||
Effect of changes in discount rate assumptions | 0 | 5 | $ 5 | $ 8 |
Beginning balance at original discount rate | 212 | 244 | ||
Effect of actual variances from expected experience | (8) | (2) | ||
Adjusted balance at beginning of period | 204 | 242 | ||
Interest accretion | 3 | 6 | ||
Net premiums collected | (7) | (7) | ||
Ending balance at original discount rate | 200 | 241 | ||
Balance at ending of period | 200 | 246 | ||
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
Balance at beginning of period | 435 | 483 | ||
Effect of changes in discount rate assumptions | (3) | (12) | (12) | (17) |
Beginning balance at original discount rate | 423 | 466 | ||
Effect of actual variances from expected experience | (9) | 1 | ||
Adjusted balance at beginning of period | 414 | 467 | ||
Net issuances | 1 | 1 | ||
Interest accretion | 5 | 9 | ||
Benefit payments | (13) | (16) | ||
Ending balance at original discount rate | 407 | 461 | ||
Balance at ending of period | 410 | 473 | ||
Accidental Death and Disability Protection | ||||
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||
Balance at beginning of period | 41 | 48 | ||
Effect of changes in discount rate assumptions | (1) | 0 | 0 | 0 |
Beginning balance at original discount rate | 41 | 48 | ||
Effect of actual variances from expected experience | 0 | 0 | ||
Adjusted balance at beginning of period | 41 | 48 | ||
Interest accretion | 0 | 0 | ||
Net premiums collected | (1) | (2) | ||
Ending balance at original discount rate | 40 | 46 | ||
Balance at ending of period | 39 | 46 | ||
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
Balance at beginning of period | 113 | 126 | ||
Effect of changes in discount rate assumptions | 2 | 0 | 0 | (1) |
Beginning balance at original discount rate | 113 | 125 | ||
Effect of actual variances from expected experience | (1) | (1) | ||
Adjusted balance at beginning of period | $ 112 | $ 124 | ||
Net issuances | 0 | 0 | ||
Interest accretion | 1 | 3 | ||
Benefit payments | (4) | (4) | ||
Ending balance at original discount rate | 109 | 123 | ||
Balance at ending of period | $ 107 | $ 123 |
Insurance - Net Liability for Future Policy Benefits (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Mar. 31, 2023 |
---|---|---|
Term and Whole Life | ||
Liability for Future Policy Benefit, Activity [Line Items] | ||
Net liability for future policy benefits | $ 210 | $ 227 |
Deferred profit liability | 13 | 15 |
Total net liability for future policy benefits | 223 | 242 |
Accidental Death and Disability Protection | ||
Liability for Future Policy Benefit, Activity [Line Items] | ||
Net liability for future policy benefits | 68 | 77 |
Deferred profit liability | 51 | 54 |
Total net liability for future policy benefits | $ 119 | $ 131 |
Insurance - Additional Information (Details) |
Mar. 31, 2024 |
Mar. 31, 2023 |
---|---|---|
Insurance [Abstract] | ||
Weighted-average duration of the liability for future policy benefits | 8 years | 8 years |
Insurance - Reconciliation of Net Liability for Future Policy Benefits To the Consolidated Statements of Financial Position (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
Mar. 31, 2023 |
---|---|---|---|
Liability for Future Policy Benefit, Activity [Line Items] | |||
Insurance claims and policyholder liabilities | $ 597 | $ 615 | $ 615 |
Term and Whole Life | |||
Liability for Future Policy Benefit, Activity [Line Items] | |||
Total net liability for future policy benefits | 223 | 242 | |
Accidental Death and Disability Protection | |||
Liability for Future Policy Benefit, Activity [Line Items] | |||
Total net liability for future policy benefits | 119 | 131 | |
Other | |||
Liability for Future Policy Benefit, Activity [Line Items] | |||
Other | $ 255 | $ 242 |
Insurance - Undiscounted and Discounted Expected Gross Premiums And Expected Future Benefits (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Mar. 31, 2023 |
---|---|---|
Term and Whole Life | ||
Expected future gross premiums: | ||
Undiscounted | $ 411 | $ 466 |
Discounted | 293 | 326 |
Expected future benefit payments: | ||
Undiscounted | 582 | 670 |
Discounted | 410 | 473 |
Accidental Death and Disability Protection | ||
Expected future gross premiums: | ||
Undiscounted | 142 | 159 |
Discounted | 101 | 114 |
Expected future benefit payments: | ||
Undiscounted | 162 | 181 |
Discounted | $ 107 | $ 123 |
Insurance - Consolidated Statements of Operations (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Term and Whole Life | ||
Liability for Future Policy Benefit, Activity [Line Items] | ||
Gross premiums or assessments | $ 13 | $ 11 |
Interest accretion | 3 | 3 |
Accidental Death and Disability Protection | ||
Liability for Future Policy Benefit, Activity [Line Items] | ||
Gross premiums or assessments | 5 | 5 |
Interest accretion | $ 1 | $ 3 |
Insurance - Actuarial Assumptions (Details) |
Mar. 31, 2024 |
Mar. 31, 2023 |
---|---|---|
Measurement Input, Mortality Rate, Expected | Term and Whole Life | ||
Market Risk Benefit [Line Items] | ||
Market risk benefit, measurement input | 0.0037 | 0.0039 |
Measurement Input, Mortality Rate, Expected | Accidental Death and Disability Protection | ||
Market Risk Benefit [Line Items] | ||
Market risk benefit, measurement input | 0.0001 | 0.0001 |
Measurement Input, Mortality Rate, Actual | Term and Whole Life | ||
Market Risk Benefit [Line Items] | ||
Market risk benefit, measurement input | 0.0038 | 0.0031 |
Measurement Input, Mortality Rate, Actual | Accidental Death and Disability Protection | ||
Market Risk Benefit [Line Items] | ||
Market risk benefit, measurement input | 0.0001 | 0.0001 |
Measurement Input, Lapses, Expected | Term and Whole Life | ||
Market Risk Benefit [Line Items] | ||
Market risk benefit, measurement input | 0.0468 | 0.0318 |
Measurement Input, Lapses, Expected | Accidental Death and Disability Protection | ||
Market Risk Benefit [Line Items] | ||
Market risk benefit, measurement input | 0.0196 | 0.0224 |
Measurement Input, Lapses, Actual | Term and Whole Life | ||
Market Risk Benefit [Line Items] | ||
Market risk benefit, measurement input | 0.0335 | 0.0167 |
Measurement Input, Lapses, Actual | Accidental Death and Disability Protection | ||
Market Risk Benefit [Line Items] | ||
Market risk benefit, measurement input | 0.0251 | 0.0034 |
Insurance - Weighted-Average Interest Rates for the Liability of Future Policy Benefits (Details) |
Mar. 31, 2024 |
Mar. 31, 2023 |
---|---|---|
Term and Whole Life | ||
Additional Liability, Long-Duration Insurance [Line Items] | ||
Interest accretion rate | 5.28% | 5.26% |
Current discount rate | 5.33% | 5.07% |
Accidental Death and Disability Protection | ||
Additional Liability, Long-Duration Insurance [Line Items] | ||
Interest accretion rate | 4.87% | 4.86% |
Current discount rate | 5.35% | 5.06% |
Capital Stock and Earnings Per Share (OMH Only) - Additional Information (Details) |
3 Months Ended |
---|---|
Mar. 31, 2024
class
| |
OMH | |
Class of Stock [Line Items] | |
Number of classes of authorized stock | 2 |
Capital Stock and Earnings Per Share (OMH Only) - Changes in Shares Issued and Outstanding (Details) - shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Beginning balance (in shares) | 119,757,277 | 121,042,125 |
Common stock issued (in shares) | 211,702 | 207,403 |
Common stock repurchased (in shares) | (108,685) | (683,384) |
Treasury stock issued (in shares) | 16,958 | 21,070 |
Ending balance (in shares) | 119,877,252 | 120,587,214 |
Capital Stock and Earnings Per Share (OMH Only) - Computation of Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Numerator (basic and diluted): | ||
Net income | $ 155 | $ 179 |
Denominator: | ||
Weighted average number of shares outstanding (basic) (in shares) | 119,829,174 | 120,765,661 |
Effect of dilutive securities (in shares) | 415,495 | 204,230 |
Weighted average number of shares outstanding (diluted) (in shares) | 120,244,669 | 120,969,891 |
Earnings per share: | ||
Basic (in dollars per share) | $ 1.29 | $ 1.48 |
Diluted (in dollars per share) | $ 1.29 | $ 1.48 |
Restricted stock units | ||
Earnings per share: | ||
Shares excluded in the diluted earnings per share calculation (in shares) | 728,403 | 1,543,976 |
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax | ||
Balance at beginning of period | $ 3,186 | $ 3,015 |
Other comprehensive income (loss) before reclassifications | (4) | 19 |
Balance at end of period | 3,214 | 3,081 |
Unrealized Gains (Losses) Available-for-Sale Securities | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax | ||
Balance at beginning of period | (93) | (131) |
Other comprehensive income (loss) before reclassifications | (6) | 19 |
Balance at end of period | (99) | (112) |
Retirement Plan Liabilities Adjustments | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax | ||
Balance at beginning of period | (8) | (8) |
Other comprehensive income (loss) before reclassifications | 0 | 0 |
Balance at end of period | (8) | (8) |
Foreign Currency Translation Adjustments | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax | ||
Balance at beginning of period | (2) | (5) |
Other comprehensive income (loss) before reclassifications | (3) | 0 |
Balance at end of period | (5) | (5) |
Changes in discount rate for insurance claims and policyholder liabilities | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax | ||
Balance at beginning of period | (5) | (8) |
Other comprehensive income (loss) before reclassifications | 5 | 3 |
Balance at end of period | 0 | (5) |
Other | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax | ||
Balance at beginning of period | 21 | 25 |
Other comprehensive income (loss) before reclassifications | 0 | (3) |
Balance at end of period | 21 | 22 |
Accumulated Other Comprehensive Income (Loss) | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax | ||
Balance at beginning of period | (87) | (127) |
Balance at end of period | $ (91) | $ (108) |
Income Taxes - Additional Information (Details) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Dec. 31, 2023 |
|
Income Tax Disclosure [Abstract] | |||
Net deferred tax asset | $ 463 | $ 477 | |
Effective tax rate | 24.10% | 24.00% | |
Unrecognized tax benefits | $ 11 | $ 11 |
Segment Information - Narrative (Details) |
3 Months Ended |
---|---|
Mar. 31, 2024
segment
| |
Segment Reporting [Abstract] | |
Number of reportable segments | 1 |
Segment Information - Schedule of Segment Information (Details) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Dec. 31, 2023 |
|
Segment Reporting Information [Line Items] | |||
Interest income | $ 1,173 | $ 1,094 | |
Interest expense | 277 | 239 | |
Provision for finance receivable losses | 431 | 385 | |
Net interest income after provision for finance receivable losses | 465 | 470 | |
Other revenues | 180 | 177 | |
Other expenses | 441 | 412 | |
Income before income taxes | 204 | 235 | |
Total assets | 23,908 | 22,443 | $ 24,294 |
Consumer and Insurance | Consumer and Insurance | |||
Segment Reporting Information [Line Items] | |||
Interest income | 1,172 | 1,092 | |
Interest expense | 276 | 238 | |
Provision for finance receivable losses | 431 | 385 | |
Net interest income after provision for finance receivable losses | 465 | 469 | |
Other revenues | 178 | 176 | |
Other expenses | 440 | 409 | |
Income before income taxes | 203 | 236 | |
Total assets | 22,672 | 21,199 | |
Other | |||
Segment Reporting Information [Line Items] | |||
Interest income | 1 | 1 | |
Interest expense | 1 | 0 | |
Provision for finance receivable losses | 0 | 0 | |
Net interest income after provision for finance receivable losses | 0 | 1 | |
Other revenues | 2 | 1 | |
Other expenses | 2 | 3 | |
Income before income taxes | 0 | (1) | |
Total assets | 18 | 30 | |
Segment to GAAP Adjustment | |||
Segment Reporting Information [Line Items] | |||
Interest income | 0 | 1 | |
Interest expense | 0 | 1 | |
Provision for finance receivable losses | 0 | 0 | |
Net interest income after provision for finance receivable losses | 0 | 0 | |
Other revenues | 0 | 0 | |
Other expenses | (1) | 0 | |
Income before income taxes | 1 | 0 | |
Total assets | $ 1,218 | $ 1,214 |
Fair Value Measurements - Fair Value & Carrying Value Hierarchy Basis (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
Mar. 31, 2023 |
[1] | |||
---|---|---|---|---|---|---|---|
Assets | |||||||
Restricted cash and restricted cash equivalents | $ 599 | [1] | $ 534 | $ 531 | |||
Total Fair Value | |||||||
Assets | |||||||
Cash and cash equivalents | 831 | 1,014 | |||||
Investment securities | 1,691 | 1,719 | |||||
Net finance receivables, less allowance for finance receivable losses | 20,293 | 20,490 | |||||
Restricted cash and restricted cash equivalents | 599 | 534 | |||||
Other assets | 39 | 40 | |||||
Liabilities | |||||||
Long-term debt | 19,224 | 19,457 | |||||
Total Carrying Value | |||||||
Assets | |||||||
Cash and cash equivalents | 831 | 1,014 | |||||
Investment securities | 1,691 | 1,719 | |||||
Net finance receivables, less allowance for finance receivable losses | 18,629 | 18,869 | |||||
Restricted cash and restricted cash equivalents | 599 | 534 | |||||
Other assets | 28 | 29 | |||||
Liabilities | |||||||
Long-term debt | 19,520 | 19,813 | |||||
Level 1 | |||||||
Assets | |||||||
Cash and cash equivalents | 807 | 1,014 | |||||
Investment securities | 55 | 54 | |||||
Net finance receivables, less allowance for finance receivable losses | 0 | 0 | |||||
Restricted cash and restricted cash equivalents | 596 | 534 | |||||
Other assets | 0 | 0 | |||||
Liabilities | |||||||
Long-term debt | 0 | 0 | |||||
Level 2 | |||||||
Assets | |||||||
Cash and cash equivalents | 24 | 0 | |||||
Investment securities | 1,633 | 1,662 | |||||
Net finance receivables, less allowance for finance receivable losses | 0 | 0 | |||||
Restricted cash and restricted cash equivalents | 3 | 0 | |||||
Other assets | 0 | 0 | |||||
Liabilities | |||||||
Long-term debt | 19,224 | 19,457 | |||||
Level 3 | |||||||
Assets | |||||||
Cash and cash equivalents | 0 | 0 | |||||
Investment securities | 3 | 3 | |||||
Net finance receivables, less allowance for finance receivable losses | 20,293 | 20,490 | |||||
Restricted cash and restricted cash equivalents | 0 | 0 | |||||
Other assets | 39 | 40 | |||||
Liabilities | |||||||
Long-term debt | $ 0 | $ 0 | |||||
|
Fair Value Measurements - Assets at Fair Value Recurring Basis (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
Mar. 31, 2023 |
[1] | |||
---|---|---|---|---|---|---|---|
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | $ 1,618 | $ 1,647 | |||||
Other securities | 73 | 72 | |||||
Restricted cash and restricted cash equivalents | 599 | [1] | 534 | $ 531 | |||
U.S. government and government sponsored entities | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 18 | 17 | |||||
Obligations of states, municipalities, and political subdivisions | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 66 | 66 | |||||
Commercial paper | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 21 | 14 | |||||
Non-U.S. government and government sponsored entities | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 154 | 167 | |||||
Corporate debt | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 1,070 | 1,085 | |||||
RMBS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 180 | 180 | |||||
CMBS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 33 | 33 | |||||
CDO/ABS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 76 | 85 | |||||
Level 1 | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Total investment securities | 55 | 54 | |||||
Restricted cash and restricted cash equivalents | 596 | 534 | |||||
Level 2 | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Total investment securities | 1,633 | 1,662 | |||||
Restricted cash and restricted cash equivalents | 3 | 0 | |||||
Level 3 | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Total investment securities | 3 | 3 | |||||
Restricted cash and restricted cash equivalents | 0 | 0 | |||||
Fair Value, Measurements, Recurring | |||||||
Assets | |||||||
Cash equivalents in mutual funds | 99 | 97 | |||||
Cash equivalents in securities | 24 | ||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 1,618 | 1,647 | |||||
Other securities | 73 | 72 | |||||
Total investment securities | 1,691 | 1,719 | |||||
Restricted cash equivalents in mutual funds | 580 | 525 | |||||
Restricted cash and restricted cash equivalents | 3 | ||||||
Total | 2,397 | 2,341 | |||||
Fair Value, Measurements, Recurring | Total bonds | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Other securities | 22 | 22 | |||||
Fair Value, Measurements, Recurring | U.S. government and government sponsored entities | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 18 | 17 | |||||
Fair Value, Measurements, Recurring | Obligations of states, municipalities, and political subdivisions | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 66 | 66 | |||||
Fair Value, Measurements, Recurring | Commercial paper | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 21 | 14 | |||||
Fair Value, Measurements, Recurring | Non-U.S. government and government sponsored entities | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 154 | 167 | |||||
Fair Value, Measurements, Recurring | Corporate debt | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 1,070 | 1,085 | |||||
Other securities | 4 | 4 | |||||
Fair Value, Measurements, Recurring | RMBS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 180 | 180 | |||||
Fair Value, Measurements, Recurring | CMBS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 33 | 33 | |||||
Fair Value, Measurements, Recurring | CDO/ABS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 76 | 85 | |||||
Other securities | 18 | 18 | |||||
Fair Value, Measurements, Recurring | Preferred stock | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Other securities | 15 | 16 | |||||
Fair Value, Measurements, Recurring | Common stock | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Other securities | 36 | 34 | |||||
Fair Value, Measurements, Recurring | Level 1 | |||||||
Assets | |||||||
Cash equivalents in mutual funds | 99 | 97 | |||||
Cash equivalents in securities | 0 | ||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 6 | 6 | |||||
Other securities | 49 | 48 | |||||
Total investment securities | 55 | 54 | |||||
Restricted cash equivalents in mutual funds | 580 | 525 | |||||
Restricted cash and restricted cash equivalents | 0 | ||||||
Total | 734 | 676 | |||||
Fair Value, Measurements, Recurring | Level 1 | Total bonds | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Other securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 1 | U.S. government and government sponsored entities | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 1 | Obligations of states, municipalities, and political subdivisions | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 1 | Commercial paper | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 1 | Non-U.S. government and government sponsored entities | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 1 | Corporate debt | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 6 | 6 | |||||
Other securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 1 | RMBS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 1 | CMBS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 1 | CDO/ABS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Other securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 1 | Preferred stock | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Other securities | 15 | 16 | |||||
Fair Value, Measurements, Recurring | Level 1 | Common stock | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Other securities | 34 | 32 | |||||
Fair Value, Measurements, Recurring | Level 2 | |||||||
Assets | |||||||
Cash equivalents in mutual funds | 0 | 0 | |||||
Cash equivalents in securities | 24 | ||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 1,611 | 1,640 | |||||
Other securities | 22 | 22 | |||||
Total investment securities | 1,633 | 1,662 | |||||
Restricted cash equivalents in mutual funds | 0 | 0 | |||||
Total | 1,660 | 1,662 | |||||
Fair Value, Measurements, Recurring | Level 2 | Total bonds | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Other securities | 22 | 22 | |||||
Fair Value, Measurements, Recurring | Level 2 | U.S. government and government sponsored entities | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 18 | 17 | |||||
Fair Value, Measurements, Recurring | Level 2 | Obligations of states, municipalities, and political subdivisions | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 66 | 66 | |||||
Fair Value, Measurements, Recurring | Level 2 | Commercial paper | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 21 | 14 | |||||
Fair Value, Measurements, Recurring | Level 2 | Non-U.S. government and government sponsored entities | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 154 | 167 | |||||
Fair Value, Measurements, Recurring | Level 2 | Corporate debt | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 1,063 | 1,078 | |||||
Other securities | 4 | 4 | |||||
Fair Value, Measurements, Recurring | Level 2 | RMBS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 180 | 180 | |||||
Fair Value, Measurements, Recurring | Level 2 | CMBS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 33 | 33 | |||||
Fair Value, Measurements, Recurring | Level 2 | CDO/ABS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 76 | 85 | |||||
Other securities | 18 | 18 | |||||
Fair Value, Measurements, Recurring | Level 2 | Preferred stock | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Other securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 2 | Common stock | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Other securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 3 | |||||||
Assets | |||||||
Cash equivalents in mutual funds | 0 | 0 | |||||
Cash equivalents in securities | 0 | ||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 1 | 1 | |||||
Other securities | 2 | 2 | |||||
Total investment securities | 3 | 3 | |||||
Restricted cash equivalents in mutual funds | 0 | 0 | |||||
Restricted cash and restricted cash equivalents | 0 | ||||||
Total | 3 | 3 | |||||
Fair Value, Measurements, Recurring | Level 3 | Total bonds | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Other securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 3 | U.S. government and government sponsored entities | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 3 | Obligations of states, municipalities, and political subdivisions | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 3 | Commercial paper | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 3 | Non-U.S. government and government sponsored entities | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 3 | Corporate debt | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 1 | 1 | |||||
Other securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 3 | RMBS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 3 | CMBS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 3 | CDO/ABS | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Available-for-sale securities | 0 | 0 | |||||
Other securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 3 | Preferred stock | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Other securities | 0 | 0 | |||||
Fair Value, Measurements, Recurring | Level 3 | Common stock | |||||||
Investments, Debt and Equity Securities [Abstract] | |||||||
Other securities | $ 2 | $ 2 | |||||
|
Subsequent Events (Details) - USD ($) $ in Millions |
Apr. 01, 2024 |
Mar. 31, 2024 |
Dec. 31, 2023 |
---|---|---|---|
Subsequent Event [Line Items] | |||
Net finance receivables | $ 21,083 | $ 21,349 | |
Auto Finance | |||
Subsequent Event [Line Items] | |||
Net finance receivables | $ 843 | $ 745 | |
Subsequent Event | Foursight Capital LLC | Auto Finance | |||
Subsequent Event [Line Items] | |||
Net finance receivables | $ 900 |
Label | Element | Value |
---|---|---|
Accounting Standards Update [Extensible Enumeration] | us-gaap_AccountingStandardsUpdateExtensibleList | Accounting Standards Update 2022-02 [Member] |
/V$RFC4T+%&] <>\PWHJD+)(L5T,2I_^%-:H7RBD&D? L2
M^EOF';S,O52.5?0Q#++5JXO!A0CDPLNC[%9M?Y4%/SV"YZLHY5^QU6LM^T+X
M>9JI=;$9%*S#6/][GPLYU#8,C!,;K&*#Q71K1$SEE9=YKU\F:BL26@UH=,&L
M\FX0%\:DE+LLP=L0^[+7;\/8BWTI;J4OPP=O'LGTY64&P/3ZTB^ O-% K!-
M;/%.Q=DJ%9,XD$%S_R4(JJBR2JK>6&?0)>
MC3OQS]$\S1)8P[_:&-5PG'8XY"$OTHWGRU<7<(%4)@_RXO5??C!=X^$4K9*H2#2^6VR!UR-(Z4J\Q%=S%B=\<2@#"\R&5E/DYBN1Z&N;S=
MHZR*;Y=;^G:E\?T*HN5%V[A1MWH\N[VX%5=GXOKF]/;TW?O9^XNK=^(3"71F
M+3E?[&:R2[R*<+=5T0V=K2<#RV(IEF3(29:V+)AK[,:%;4S@I[53L*LU"I3%
M]L$HWA,G3%3,I#,7J1_SF;77 XEG/-H@U0L0_HWJ "
MMW%'V<>+4]_/!?#